US research institute, part of National Institutes of Health
POPULARITY
Categories
https://lewishowes.com/mindset - Order a copy of my new book The Greatness Mindset today!Peter Attia, MD, is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. He is the host of The Drive, one of the most popular podcasts covering the topics of health and medicine. He is also the author of the #1 New York Times Bestseller, Outlive: The Science and Art of Longevity. Dr. Attia received his medical degree from the Stanford University School of Medicine and trained for five years at the Johns Hopkins Hospital in general surgery, where he was the recipient of several prestigious awards, including resident of the year. He spent two years at the National Institutes of Health as a surgical oncology fellow at the National Cancer Institute, where his research focused on immune-based therapies for melanoma.In this episode you will learn,The two main purposes our muscles serve.Some of the best sources of plant based protein.The risk and cause of heart disease and how to prevent it.The leading causes of cancer.The main causes of Alzheimer's disease and dementia.Healthy practices to improve the longevity and quality of your life.For more information go to www.lewishowes.com/1438Check out Peter Attia's website: https://peterattiamd.com/The Science of Sleep for Ultimate Success with Shawn Stevenson: https://link.chtbl.com/896-podA Scientific Guide to Living Longer, Feeling Happier & Eating Healthier with Dr. Rhonda Patrick: https://link.chtbl.com/967-podThe Wim Hof Experience: Mindset Training, Power Breathing, and Brotherhood: https://link.chtbl.com/910-pod
In this episode of “This Is Purdue,” the podcast team is taking our listeners behind the scenes during the Purdue Institute for Cancer Research's 15th annual Challenge 5K run/walk. More than 900 runners and walkers participated in this year's Challenge, raising more than $100,000 for lifesaving cancer research. As one of only seven National Cancer Institute-designated Basic Laboratory Cancer Centers in the U.S., the Institute for Cancer Research generated more than 150 patents during the past decade, and its members have over 40 drugs in various stages of development. More than 110 researchers across Purdue University share ideas, insights and findings to drive cancer research, with a shared goal of creating a world without cancer. Listen as we talk to The Challenge's 2023 guests of honor, Tony and Kelly Trent, parents of the late Tyler Trent, a 20-year-old Purdue student from Carmel, Indiana, who passed away from a rare form of bone cancer in 2019. Tony and Kelly share more about what the word “persistence” means to their family – and what it meant to Tyler – and why the research the Purdue Institute for Cancer Research conducts is so important in providing hope to cancer patients and survivors.
Peter Attia received his medical degree from Stanford University School of Medicine, trained for five years at Johns Hopkins Hospital in general surgery, and spent two years with NIH as a surgical oncology fellow at the National Cancer Institute. He is the founder of Early Medical, a medical practice focused on lifespan and healthspan, the host of The Drive podcast, and author of the #1 New York Times–bestseller Outlive. Today, Attia explains how to mitigate cognitive decline, the technologies he's most excited about, and ways to optimize your sleep and exercise routines. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
The early 1970's saw the start of the medical specialty we now know as oncology. How does one create standards and practices for patient care during that time? Dr. John Glick is a pioneer during the dawn of oncology. He says that early work involved humanity, optimism, and compassion, all of which were the foundation of his career. Dr Glick describes the clinical experiences that drove him to oncology (4:28), his rapport with patients, which was portrayed in Stewart Alsop's book Stay of Execution (9:21), and his groundbreaking work developing the medical oncology program at the University of Pennsylvania (12:22). Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. John Glick: None More Podcasts with Oncology Leaders Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1) Oncology, Etc. – HPV Vaccine Pioneer Dr. Douglas Lowy (Part 1) Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1) If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Disclosures for this podcast are listed in the podcast page. Pat Loehrer: Welcome to Oncology, Etc. This is an ASCO education podcast. I'm Pat Loehrer, Director of Global Oncology and Health Equity at Indiana University. Dave Johnson: And I'm Dave Johnson, a medical oncologist at the University of Texas Southwestern in Dallas, Texas. If you're a regular listener to our podcast, welcome back. If you're new to Oncology, Etc., the purpose of our podcast is to introduce listeners to interesting people and topics in and outside the world of oncology. Today's guest is someone well-known to the oncology community. Dr. John Glick is undoubtedly one of oncology's most highly respected clinicians, researchers, and mentors. I've always viewed John as the quintessential role model. I will add that for me, he proved to be a role model even before I met him, which hopefully we'll talk about a little bit later. To attempt to summarize John's career in a paragraph or two is really impossible. Suffice it to say, he is to the University of Pennsylvania Cancer Center what water is to Niagara Falls. You can't have one without the other. After completing his fellowship at NCI in Stanford, John joined the Penn faculty in 1974 as the Ann B. Young Assistant Professor. Some five decades later, he retired as the director of one of the most highly respected comprehensive cancer centers in the nation. Among his many notable accomplishments, I will comment on just a few. He established the Medical Oncology program at Penn and subsequently directed the Abramson Cancer Center from 1985 to 2006. Interestingly, he established the Penn Medicine Academy of Master Clinicians to promote clinical excellence in all subspecialties across the health system. He's been a driving force in philanthropy at Penn Medicine, culminating in his role as Vice President Associate Dean for Resource Development. Over the past several decades, he has helped raise over half a billion dollars for Penn Med. We need you on our team, John. As a clinician scholar, John's research has helped shape standards of care for both breast cancer and lymphomas. For example, he pioneered the integration of adjuvant chemotherapy and definitive breast irradiation for early-stage breast cancer. In 1985, he chaired the pivotal NCI Consensus Conference on adjuvant chemotherapy for breast cancer. He also was a driving force in a clinical landmark study published in The New England Journal some 20 or so years ago about the role of bone marrow transplant for advanced breast cancer. Most impressive of all, in my opinion, is John's legacy as a mentor to multiple generations of medical students, residents, and fellows. So, John, we want to thank you for joining us and welcome. Thought we might start by having you tell us a little about your early life, your family, your parents, where you grew up, and how you got into medicine. Dr. John Glick: Well, thank you for having me on the podcast, Pat and David, it's always a pleasure to be with you and with ASCO. I grew up in New York City in Manhattan. My father was a well-known dermatologist. He was my role model. And from the age of eight, I knew I wanted to be a doctor. Nothing else ever crossed my mind. But having seen my father's many interests outside of medicine, I realized from very early that there was much more to medicine than just science. And that really induced me, when I went to college, to major in the humanities, in history, art history, and I actually took the minimum number of science courses to get into medical school. That probably wouldn't work today, but it was the start of my interest in humanism, humanities, and dealing with people outside of the quantitative sciences. Dave Johnson: So that's reflected in how we all view you, John. You're one of the most humanistic physicians that I know personally. I wonder if you could tell us about your interest in medical oncology, and in particular, as one of the pioneers in the field. I mean, there wasn't really even a specialty of medical oncology until the early 1970s. So, how in the world did you get interested in oncology and what drew you to that specialty? Dr. John Glick: Well, I had two clinical experiences that drove me into oncology. The first, when I was a third year medical student at Columbia PNS, my first clinical rotation in internal medicine, I was assigned a 20-year-old who had acute leukemia, except he was not told his diagnosis. He was told he had aplastic anemia, receiving blood and platelets, and some form of chemotherapy. And I spent a lot of time just talking to him as an individual, not just taking care of him. And we became friends. And he was then discharged, only to be readmitted about two weeks later. And in the elevator, the medical assistant had his admission sheet, and unfortunately, it was facing the patient, and it had his diagnosis, acute leukemia. So he came into the ward and he confronted me. "Why didn't you tell me I had acute leukemia?" Well, I couldn't say the attendees forbade me to do that. So I took what today we would call ‘the hit', and apologized. But it stimulated me to reflect that honesty with patients was extremely important, and that oncology was just in its infancy. We knew nothing about it. It was not considered even a specialty. I don't think we used the word "oncology." But that inspired me to take an elective in my fourth year at PNS, at an indigent cancer hospital called the Francis Delafield Hospital. It only took care of indigent cancer patients, and there were wards, twelve patients in a ward, six on each side, and nobody would go see the patients. It was almost as if they were afraid that if they were to touch the patient, they would get cancer. And I started talking to the patients, and they were human beings, but nobody had told them their diagnosis. Nobody had told them if they were terminal. And there were a few patients who were getting a new drug at that time for multiple myeloma called melphalan, and they actually had relief of some of the symptoms, of their bone pain. But I realized that there was a huge void in medicine that I could possibly help to fill. And that was the era of Vietnam, and so I applied to the National Cancer Institute to become a commissioned officer in the Public Health Service to avoid the draft, to be on a service with, at that time, some very notable oncologists Vince DeVita, Ed Henderson, Paul Carbone. I had read some of their papers, and I was lucky to be accepted. And I was a clinical associate at the National Cancer Institute. And that was life-changing because there every patient was considered to be potentially curable. The advances at that time using MOPP for Hodgkin's disease, C-MOPP for lymphoma, some treatments for leukemia. George Canellos pioneered the use of CMF for metastatic breast cancer. It was an amazing, amazing experience. That was in 1971 to ‘73. Oncology did not become a true specialty till ‘73, but my two years at NCI were formative. However, I realized that there was something missing in my training. Everybody was considered curable, but I had never seen a patient with metastatic colon cancer, metastatic lung cancer. The radiotherapists there did not like to teach clinical associates, and I knew that there was a place called Stanford. And Stanford had Saul Rosenberg in medical oncology for lymphomas and Henry Kaplan in radiotherapy. So, everybody was going to California, and my wife and I packed up and went to California and spent a year at Stanford, which, combined with my training at the NCI, led me to the principles that guided my career in oncology; humanity, optimism, reality, compassion, and a love for clinical trials. I was very, very fortunate to be there at the dawn of medical oncology shortly after I decided to go to Penn, which at that time did not have a medical oncologist. In fact, I was the only medical oncologist at Penn for four years and did every consult in the hospital for four years, much to the chagrin of my wife. But I was fortunate to have great mentors in my career: Paul Carbone, Vince DeVita, Saul Rosenberg, Henry Kaplan, among many, many others. And that impressed me about the importance of mentorship because my career would never have been where it was or is without these mentors. Pat Loehrer: John, just to echo what Dave said, you've been such a tremendous mentor for us. Dave and I particularly, you took us under your wings when you didn't know who we were. We were people in the Midwest. We weren't from any place shiny, but we really appreciate that. Dave Johnson: So, John, I mentioned at the very beginning that I met you before I met you, and the way I met you was through Stewart Alsop's book, Stay of Execution. He portrayed you as an extraordinarily caring individual, and it tremendously impacted me. It was one of the reasons why I chose oncology as a specialty. I realize it's been 50 or more years ago and most of our listeners will have no idea who Stewart Alsop was. And I wonder if you might share with us a little bit of that experience interacting with someone who was particularly well-known in that time as a columnist for The New York Times. Dr. John Glick: His brother Joe Alsop and Stu Alsop were two of the most famous columnists at that time. Joe Alsop was a hawk right-winger who lived in the Vietnam War. Stewart was charming, was a centrist Democrat, wrote the back page for Newsweek for years. He and I had very similar educational backgrounds and interests. And we functioned on two different levels—one as a physician-patient, and then we became friends. And he and his wife adopted us into the Georgetown set. And I received a lot of criticism for socializing with a patient. But over the years, I've been able to become friends with many of my patients, and I've been able to compartmentalize their medical care from our friendship. And I use the analogy if I was a doctor in a small town and I was the only doctor, I'd be friends with people in town, with the pastor and likely the mayor. But I have always believed that patients can become your friends if they want it and if they initiated it. Taking care of Stewart Alsop was an amazing, amazing experience. We didn't know what he had. People initially thought he had acute leukemia. In reality, he had myelodysplastic syndrome, but that hadn't been described yet. He had a spontaneous remission, which I rarely see, probably due to interferon released from a febrile episode, all his blasts went away in his marrow. One of my children's middle name is Stewart. But professionally and personally, it was an incredible experience. It taught me the importance of being available to patients. They had my home phone number. We didn't have cell phone numbers in those days. We had beepers, but they didn't work. And from that point on, I gave my home phone number to patients, and I actually trained my children how to answer the phone. “This is Katie Glick. How can I help you? My father's not home. You need my father? Can I have your phone number? I'll find him and he'll call you back.” Patients still remember my children and their way of answering the phone. Pat Loehrer: One of the things you did do is create this medical oncology program at Penn, which has graduated some incredible fellows that have become outstanding leaders in our field. But can you reflect a little bit about the process of creating something that was never created before, like a medical oncology program? Dr. John Glick: Well, I came to Penn, my first day. Person who recruited me was on sabbatical. I asked where my office was and there was no office. There was an exam room. There was a clinic for indigent patients which we scrubbed by hand. There was another office for patients who paid. Within two months, I had abolished that. We had one– I hate to use the word clinic, people still use the word clinic today, but one office that took care of all patients, irregardless of means. I saw every oncology consult in the hospital for four years. But I had a mentor, not only Buz Cooper, but fortunately, Jonathan Rhoads was Chairman of Surgery, and he was also Chairman of the President's Cancer panel. And what he said at Penn in surgery became the law. And then when we introduced lumpectomy for breast cancer and radiotherapy, he endorsed it immediately. All the other surgeons followed suit. I don't think there's any hospital in the country that adopted lumpectomy and radiotherapy for breast cancer as quickly. And the surgeons were instrumental in my career. Now, I was taking care of gliomas, head and neck cancers, and it was difficult. If I had a colorectal patient, I'd call Charles Moertel at Mayo Clinic and say, “What do I do?” I was there when Larry Einhorn in 1975 presented his data on testicular cancer with the platinum. Unbelievably inspiring, transformational. It also showed the importance of single-arm studies. You didn't have to do randomized studies because the results were so outstanding. And so in my career, I did both single-arm studies, proof of principle studies, and then many randomized trials through the cooperative groups. But the first four years were very difficult. I didn't know what the word ‘work-life balance' meant in those days. If somebody was sick, I stayed and saw them. It was difficult introducing new principles. When I first mentioned platinum after Larry's presentation, I was laughed out of the room because this was a heavy metal. When patients were dying, they died in the hospital, and I wanted to hang up morphine to assist them. The nurses reported me to the administration. I had to fight to get the vending machines for cigarettes out of the hospital. So there were a lot of victories along the way and a lot of setbacks. It took me several years to have an oncology unit of six beds, and now I think we have 150 or 160 beds and need more. So it was an interesting and, in retrospective, a wonderful experience, but I didn't know any better. Fortunately, I had a great wife who was working at Penn and then at Medical College of Pennsylvania, and she was incredibly understanding, never complained. And I think my kids knew that on Tuesdays and Thursdays, don't bring up anything difficult with dad because he's had a really tough day in clinic. Dave Johnson: We were not in that era, but we were very close. And many of the struggles that you had were beginning to dissipate by the time we were completing our training. But it was still a challenge. I mean, all those things. I gave my own chemotherapy for the first few years I was in practice. I don't know that our colleagues today who have trained in the last, say, 10 or 15 years, actually realize that that was what we did. Most of the chemo was given in the hospital. It was not uncommon in the early days to have 20, 30, 40 inpatients that you would round on because there just wasn't an outpatient facility. But the corporate mind made a big difference, allowing us to give drugs like platinum in the outpatient arena. You span all of that era, and so you've seen the whole panoply of change that has taken place. John, the other thing you did that has impressed me, in part because of my time as a Chair of Medicine, is you created this Academy of Master Clinicians. Can you tell us a bit about that and what was the motivation behind that? Dr. John Glick: Ben had a strategic plan, and one of the pillars was talking about valuing clinical medicine and clinical excellence. But there was no implementation plan. It was sort of just words and left in the air. And I was no longer director of the cancer center, and I realized we had a lot of awards for research, awards for education, and no awards for clinical excellence. So I created the idea of having an academy and master clinician spend six months talking to all constituencies, chairs of various departments, directors of centers to get a buy-in. Wrote a three-page white paper for the dean, who approved it immediately. And then, as typical at Penn, I raised all the money for it. I went to one of my patients who was an executive at Blue Cross. I said I need $500,000 to start this program. And then subsequently, I raised $4 million to endow it. Today, it is the highest honor that a Penn clinician can receive. You could be on any one of our multiple tracks. You have to see patients at least 60% of the time. You not only have to be a great doctor, you have to be a humanist. So the world's best thoracic surgeon who has a demeanor in the operating room that is not conducive to working with a nurse as a team doesn't get in. We emphasize professionalism, mentorship, citizenship, teaching, national reputation, local reputation, and clinical excellence. And so we've elected over 100 people, maybe 3% of the Penn faculty. We give an honorarium. We have monthly meetings now by Zoom. We have monthly meetings on various topics. We never have a problem getting any dean or CEO to come talk to us. We were the first to do Penn's professionalism statement. The school subsequently adopted, and it's become the highest honor for a Penn clinician. It's very competitive. It's peer-reviewed. The dean has no influence. And we're very proud that 40% of the members of the academy are women. We have a high percentage of diversity compared to the numbers on our faculty, but you really have to be elected on merit, and some people that you might expected to be members of the academy aren't. It's one of the things I'm proudest of. It will go on in perpetuity because of the money we've raised. I think many of my accomplishments as a researcher will fade, as they typically do, but I'm very proud of the Academy, and I'm very proud of the people that I've mentored. Dave Johnson: It speaks to your values, John, and I think it's one of the reasons why you're so widely admired. Thank you for creating that. It proved to be a model for other institutions. I know that for a fact. One would think that valuing clinical care would be preeminent in medical schools, but in fact, it's often ignored. So again, I know that your colleagues at Penn appreciate your efforts in that regard. Tell us a little about your term as ASCO president. What are you most proud about and what were your most difficult challenges? Dr. John Glick: Well, the most difficult challenge was that ASCO was in transition. I had to fire the company that ran the meeting. We had to decide that ASCO was going to hire a CEO. We hired John Durant, made a small headquarters, tiny staff, and did a lot of the work as being chief operating officer myself. It was the year that email was just getting started, and ASCO wasn't using it. So every Saturday from 8:00 to 6:00, I came into the office and my secretary wrote letters inviting people to be on the program committee or various committees. But it was a society in transition. The growth of membership was huge. The meeting sites had to be changed. We emphasized science. Some of the things that we did are still in existence today. We formed the ASCO ACR Clinical Research Methods course. It's still given. That's one of our real highlights. We forged relationships with other societies, the National Coalition for Survivorship. We made the ASCO guidelines much more prominent. And I remember that we were going to publish the first guidelines on genetic testing for breast cancer, and the MCI went up in absolute arms, so I arranged a meeting. I was at the head of the table. On my right were Francis Collins, Richard Klausner, Bob Wittes, and a few other people. Then the ASCO people who wrote the guideline were on the left, and they didn't want us to publish it. They thought it was premature to have a guideline about genetic testing. And what I learned from that meeting is that you can agree to disagree with even the most prominent people in oncology and still maintain those relationships. But we did what's right, and we published a guideline on the JCO. There were so many wonderful things that happened at ASCO that I can hardly restate all that happened I guess 27 years later. It was exciting. ASCO was still young. There was a lot we had to do, and we could do it. You could just go ahead and do it. It was exciting. It was gratifying. It was one of the most fun years of my life. Dave Johnson: I mean, that transition from an outside company in many respects, controlling the premier activity of ASCO, its annual meeting to ASCO, taking that on, that defined ASCO, and that's what I remember most about your time as president. It was a bold move, and the hiring of John Durant was brilliant. I mean, he was such an incredible individual, and it was great that you guys were able to pull that off. Pat Loehrer: Thank you for what you've done. You've had a number of your mentees if you will, and colleagues that have gone on to prominent positions, including, I think, at least three directors of NCI Cancer Centers. Can you just talk briefly how you would describe your mentoring style because you've been so successful? Dr. John Glick: First, there are two aspects. One is when people come to you, and then when you go to people, you sense they're in need. The key aspect of mentoring is listening. Not talking, listening. Looking for the hidden meanings behind what they're saying, not telling them what to do, presenting options, perhaps giving them clues on how to weigh those options in pros and cons, being available for follow-up. Mentoring is never a one-time exercise. Not criticizing their decisions. You may disagree with their decision, but it's their decision, especially if they've considered it. Being proud of the mentee, being proud of their accomplishments, following them over the years. And when they've gotten in trouble or failed to get the job that they wanted, always be there for them, not just in the good times, but in the times that are difficult for them professionally. I think that's one of the most important things. Even today, I mentor three or four clinical department chairmen, and people ranging from full professors to newly appointed assistant professors. Now that I'm retired, mentoring is the one activity that I've really retained. It's extraordinarily satisfying, and I'm proud of the people that I've mentored. But it's their accomplishments, and the key aspect of mentoring is never to take credit. Dave Johnson: I'll give you credit for mentoring me, and I appreciate it. You were very instrumental at a very decisive point in my career when the old Southeast Cancer Group disbanded, and we were looking for a new cooperative group home. And you were instrumental in helping my institution come into the ECOG fold, and not just as a very junior member, but really as a player. And I'll never forget that, and we'll always appreciate that very much. Pat Loehrer: Ditto on my side, too. Dave Johnson: John, you mentioned that you're retired. What do you like to do in your "free time” if you're not mentoring? Dr. John Glick: Life is good. My daughter says I have a disease, O-L-D. My grandson says, “He's not old; he's almost 80. Look how well he's done.” “Here's $20.” I'm having fun. We are fortunate to have homes in different places. We spend the summer up in the Thousand Islands on the St. Lawrence River, spring and fall down in Charleston, then lots of time in Philadelphia. We travel. I play golf poorly. I'm getting a chance to read history again, go back to one of my great loves. I'm with my children and grandchildren more. I lost my first wife. I've been remarried for about twelve years, and I'm enjoying every moment of that. I'm not bored, but I do wake up in the morning with no anxiety, no realization that I have to herd sheep or herd cats. I have no metrics, I have no RVUs, not behind of the EMR. Dave Johnson: You're making it sound too good, John. Dr. John Glick: We're having fun. And I have not been bored. I've not been down in the dumps. Each day brings a different aspect. We see a lot more of our friends. I exercise. I deal with the health problems that people get when they get older, and I have plenty of those. Seeing doctors takes a lot of time, but I'm grateful that I'm having these few years of retirement. I'm one of the people who is most fortunate to have attained everything they wanted to do in their professional life, and now I'm trying to do some of the same in my personal life. Dave Johnson: John, Pat and I both love to read. We love history. You mentioned that you're reading some history. Is there a book that you've read recently that you might recommend to us? Dr. John Glick: “the Last of the Breed” {With the Old Breed} It's about a private in the Pacific campaign who was not a commissioned officer; it's just a grunt on the ground. It brings the horrors of the Pacific island campaigns to life. But there's a huge number of books, some historical fiction. I'm a great fan of Bernard Cornwell, who's written about the Medieval times, Azincourt, 1356. I'll read two or three books a week. I'm devoted to my Kindle. Dave Johnson: If you could go back in time and give your younger self a piece of advice, what would that advice be? Dr. John Glick: Try and achieve more of a work-life balance. I didn't have any choice. If I didn't do the consult, it didn't get done. That's not the situation today. But I have a second piece of advice, don't treat medicine as a 9 to 5 job. If a patient is sick, stay with the patient. Give the patient your home or cell phone number. Remember, medicine is not just a profession, but it can be a calling. Too few of our physicians today regard medicine as a calling. And even if you're employed, as most of us are by an academic or other institution, do what's right for the patient, not just what's right for your timesheet or the EMR. Remember that the patient is at the center of all we do and that medicine is a calling for some people, as it was for me. Dave Johnson: Great advice, John. Great advice. Well, I want to thank Dr. Glick for joining Pat and me. This has been a delight. You're one of our role models and heroes. I want to thank all of our listeners of Oncology, Etc., which is an ASCO educational podcast where we will talk about oncology medicine and other topics. If you have an idea for a topic or a guest you'd like us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content of ASCO, please visit education.asco.org. Thanks again. Pat, before we go, I've got an important question for you. I've been trying to school you recently, and you've failed miserably. So I'm going to ask you, why is it that McDonald's doesn't serve escargot? Pat Loehrer: I can't do it. I don't know. I give up. Dave Johnson: It's not fast food. Pat Loehrer: I like that. It's good. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experiences, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
In Episode #34 I will discuss the beautiful but venomous Copperhead snake. Your host is Tommy Fowler. I have a biology degree from the University of Kentucky and a high passion for the outdoors. I am "The Amateur Naturalist".**** Click here to get $20 off a paid Buzzsprout account to start your own podcast. It's fun, start today!! Buzzsprout is an awesome podcast host site. Go take a look!!https://www.buzzsprout.com/?referrer_id=2014700We will talk about:In this episode I will discuss the Copperhead snake.I will also discuss where they are found.What do these snakes eat?What predators eat this snake?What are these Hershey's Kisses that you speak of????Do they lay eggs or do they actually have live birth?Reproduction Food sourcesPlease tell me any stories that you might have and you can tell me on my Facebook site for the Amateur Naturalist podcast. I would love to hear your stories!!There will be an advertisement for Buzzsprout so if you want to make your own podcast you can click in my show notes the Buzzsprout link and I have an offer to you for $20 off. It cost only $12 per month to do a podcast and you can add to that with further upgrades BUT I do not. Just $12 per month.My website:https://theamateurnaturalist.buzzsprout.com/2032491Be sure to visit Facebook and look for my site ... The Amateur NaturalistI would love to hear your ideas, see pictures or hear your feedback.**************** You can help me out by: *******************Please hit “download” on every episodePlease hit Followplease leave me a reviewdownload each of my episodesplease leave a 5-star rating This helps me grow as a podcaster please tell 1-2 friends or family about this podcast**** Click here to get $20 off a paid Buzzsprout account to start your own podcast. It's fun, start today!! Buzzsprout is an awesome podcast host site. Go take a look!!https://www.buzzsprout.com/?referrer_id=2014700The short music intro and outro is:"Hickory Hollow" by Dan Lebowitz.I love this music. Thank you, Dan.This music is royalty free.Sources this week:1) Finn, Robert; "Snake Venom Protein Paralyzes Cancer Cells"; Journal of the National Cancer Institute; Pages 261-2622) "Venomous Snakes"; (https://www.cdc.gov/snakes)3) "Copperhead Snakes"; A-Z Animals.com4) "Southern Copperhead Snakes"; Wikipedia
About 90% of nonmelanoma skin cancers are associated with ultraviolet radiation exposure. Sometimes prevention is straight forward: wear sunblock, stay shaded. But still, there are 1 million skin cancer diagnoses in the U.S. every year. Ultraviolet dosimeters are one of several technologies that are showing a lot of promise when it comes to preventing skin cancer. The tools collect personalized data about UV exposure and are linked to an app that allows people to enter information about their sun-protective behaviors like wearing sunscreen. Psychologist Frank Perna, program director at the National Cancer Institute (NCI)'s Division of Cancer Control and Population Sciences, Behavioral Research Program, and Health Behaviors Research Branch, discusses how programs like the Surveillance, Epidemiology and End Results (SEER) Program and the Classification of Laws Associated with School Students (CLASS) are helpful in tracking melanoma as well as capturing data about state policies related to sun safety and sunscreen use in schools.
“It's very easy to sit and read a recipe but the key is not going on a diet— you really need to adjust your way of life." —Stephen Freedland M.D. Eating healthy is not just about looking good, it is also about feeling good. Food has been used as medicine for centuries, and with the right knowledge and eating habits, we can use food to heal ourselves. This week, Dr. Stephen Freedland delivers compelling reasons we must rethink our eating habits and lifestyle. Dr. Freedland is a leader in the field of urology, with expertise in the diagnosis and treatment of benign prostatic hyperplasia (BPH) and prostate cancer. He has contributed significantly to cancer prevention and awareness through a patient-centered approach that focuses on understanding the whole person rather than just the disease. Join in as Dr. Freedland outlines a decade worth of research on how carbohydrate affects tumor growth, the challenges of conducting a clinical trial, how a personalized lifestyle can make greater impact, how we can gain more control over our health journey, and what can help us make better choices not only for our health but for our future. Meet Stephen: Stephen Freedland, MD, is the director of the Center for Integrated Research in Cancer and Lifestyle, co-director of the Cancer Genetics and Prevention Program, and associate director for Faculty Development at the Samuel Oschin Comprehensive Cancer Institute. He is a faculty physician in the Division of Urology at the Cedars-Sinai Department of Surgery. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia, and prostate cancer. His approach toward cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional Western medicine with complementary holistic interventions. His research interests include urological diseases and the role of diet, lifestyle, and obesity in prostate cancer development and progression, as well as prostate cancer among racial groups and risk stratification for men with prostate cancer. Freedland has published over 400 studies, and his research has appeared in the Journal of the American Medical Association, Journal of the National Cancer Institute, Journal of Clinical Oncology, Journal of Urology, Cancer Prevention Research, Cancer and BJUI, among others. Freedland is an active reviewer for more than 50 journals. He sits on the editorial board for Cancer Prevention Research, European Urology, International Journal of Urology, Nature Reviews Urology and BJUI, and serves as editor-in-chief for Prostate Cancer and Prostatic Diseases and as a consulting editor for European Urology. Freedland earned his MD from the University of California, Davis. He completed a residency in urology at UCLA and a fellowship in urological oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University, where he specialized in surgical oncology and urologic oncology, and served as an associate professor in the Division of Urology. Twitter LinkedIn Connect with Cedar-Sinai Medical Center: Website Facebook Twitter Instagram LinkedIn YouTube Connect with NextGen Purpose: Website Facebook Instagram LinkedIn YouTube Episode Highlights: 01:00 The Link Between Food and Cancer 06:49 Carbohydrate and Tumor Growth 12:15 Measurable Outcomes 16:25 Personalizing Lifestyle 22:06 Be an Active Participant in Your Health Journey 30:33 Make Better Choices
In Episode 44 of Bladder Cancer Matters, host Rick Bangs talks with Thomas Flaig, MD, a genitourinary cancer medical oncologist and vice chancellor for research for the University of Colorado Denver and Anschutz Medical Campuses. In addition to his clinical and administrative work, Dr. Flaig has significant clinical and translational research experience, having led both local and national multi-center clinical trials. Known nationally for his work on bladder cancer, Dr. Flaig has been a member of the National Cancer Institute's Investigational Drug Steering Committee and the bladder cancer task force. Rick and Dr. Flaig talk about bladder cancer treatment guidelines and why they should matter to patients and the survivors. They discuss: What defines guidelines How many bladder cancer guidelines there are What those who are developing the guidelines do when new evidence comes out that could impact treatments The process of generating a patient-friendly version of guidelines How doctors apply guidelines to patients and if it is art, science, or both The most significant changes that Dr. Flaig has seen in his 10 years of working on bladder cancer guidelines Never miss an episode of Bladder Cancer Matters by subscribing in your favorite podcasting platform.
A new editorial paper was published in Oncotarget's Volume 14 on April 10, 2023, entitled, “Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity.” In this new editorial, researchers Zhaoshan Liu, Swati Choksi and Zheng-Gang Liu from the National Institutes of Health's National Cancer Institute discuss cell death—which can happen as finely regulated programmed cell death (PCD) or non-regulated accidental cell death (necrosis). In addition to apoptosis, which is the first known PCD, several other forms of PCD such as necroptosis and ferroptosis have been identified and the underlying mechanisms of these forms of cell death have been well studied. For necroptosis, a regulated necrotic cell death, Mixed lineage kinase domain-like protein (MLKL) was found to be the key executor of the death process and its oligomerization and translocation to the plasma membrane results in the shedding of cell surface proteins and the rupture of the cell plasma membrane of necroptotic cells. The role of the different forms of PCD in tumorigenesis has been extensively investigated. While apoptosis and ferroptosis inhibit tumor progression, necroptosis seems to have a promoting role in tumor progression. The researchers here recently found that necroptosis is the main form of cell death observed in tumor necrosis, the foci of cell death in core regions of solid tumors under hypoxia and nutrient deprivation. More importantly, they found that blocking necroptosis leads to the inhibition of metastasis in mouse breast cancer models. “Developing novel necroptosis inhibitor[s] by targeting other proteins such as MLKL may be critical for successfully blocking necroptosis in cancer and mitigating metastasis.” Full editorial: DOI: https://doi.org/10.18632/oncotarget.28404 Correspondence to - Zheng-Gang Liu - zgliu@helix.nih.gov Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28404 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - necroptosis, breast cancer, metastasis, E-cadherin, immunity About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957
When you're searching for personal care products, whether a bar of soap or a bottle of lotion, are you reading the ingredients label? What harmful ingredients should be avoided? A recent study from the Journal of the National Cancer Institute found potential links between the regular use of hair straightening products like relaxers that contained "formaldehyde and formaldehyde-releasing chemicals," and uterine cancer, prompting a new federal lawsuit. There have been similarly troubling findings and lawsuits around some deodorants containing benzene, and powders containing talc contaminated with asbestos. Researchers at the University of Notre Dame found PFAS, sometimes called "forever chemicals," in 52% of cosmetics. Only a fraction of those products listed PFAS on the label. This hour, we hear from local makers who are focused on safe and natural ingredients. Plus, the Environmental Working Group has been building a searchable database of different products and ingredients for almost two decades, hoping to make it easier for consumers to shop smart. GUESTS: Melanie Benesch: Vice President of Government Affairs, Environmental Working Group Christine Palm: Connecticut Democratic State Representative, 36th District Sami Jo Artus: Founder and Chief Beauty Maker, florapothecarie Mecca Davis-Provite: Owner, Rootuals Natural Hair Care Where We Live is available as a podcast on Apple Podcasts, Spotify, Google Podcasts, Stitcher, or wherever you get your podcasts. Subscribe and never miss an episode. Cat Pastor contributed to this show which originally aired March 9, 2023.Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.
Today is a very special episode: You are all going to be the very, very first people to hear me read Chapter 1 of FAT TALK: Parenting in the Age of Diet Culture, which comes out in just 5 days, on April 25. We are excerpting this from the audiobook, which I got to narrate. If you love what you hear, I hope you will order the audiobook or the hardcover (or if you're in the UK and the Commonwealth, the paperback) anywhere you buy books. Split Rock has signed copies and don't forget that when you order from them, you can also take 10 percent off anything in the Burnt Toast Bookshop.If you want more conversations like this one, please rate and review us in your podcast player! And become a paid Burnt Toast subscriber to get all of Virginia's reporting and bonus subscriber-only episodes. Disclaimer: Virginia and Corinne are humans with a lot of informed opinions. They are not nutritionists, therapists, doctosr, or any kind of health care providers. The conversation you're about to hear and all of the advice and opinions they give are just for entertainment, information, and education purposes only. None of this is a substitute for individual medical or mental health advice.LINKSThat photo by Katy Grannanarchived in the National Portrait Gallery's Catalog of American PortraitsAnamarie Regino on Good Morning AmericaLisa Belkin's NYT Magazine articlea report published in Children's Voicea judge ordered two teenagers into foster care2010 analysis published in the DePaul Journal of Health Care LawFat Shame: Stigma and the Fat Body in American CultureFearing the Black BodyHilde Bruch's research papersNational Association to Advance Fat Acceptance (NAAFA)Judy Freespirit and Aldebaran wrote the first “Fat Manifesto”Several studies from the 1960sresearchers revisited the picture ranking experimentthe 1999–2000 NHANES showed a youth obesity rate of 13.9 percentreaching 19.3 percent in the 2017–2018 NHANESData collected from 1976 to 1980 showed that 15 percent of adults met criteria for obesity.By 2007, it had risen to 34 percent.The most recent NHANES data puts the rate of obesity among adults at 42.4 percent.The NHANES researchers determine our annual rate of obesity by collecting the body mass index scores of about 5,000 Americans (a nationally representative sample) each year.A major shift happened in 1998, when the National Institutes of Health's task force lowered the BMI's cutoff points for each weight category, a math equation that moved 29 million Americans who had previously been classified as normal weight or just overweight into the overweight and obese categories.in 2005, epidemiologists at the CDC and the National Cancer Institute published a paper analyzing the number of deaths associated with each of these weight categories in the year 2000 and found that overweight BMIs were associated with fewer deaths than normal weight BMIs.in 2013, Flegal and her colleagues published a systematic literature review of ninety-seven such papers, involving almost three million participants, and concluded, again, that having an overweight BMI was associated with a lower rate of death than a normal BMI in all of the studies that had adequately adjusted for factors like age, sex, and smoking status.But in 2021, years after retiring, Flegal published an article in the journal Progress in Cardiovascular Diseases that details the backlash her work received from obesity researchers.After her paper was published, former students of the obesity researchers most outraged by Flegal's work took to Twitter to recall how they were instructed not to trust her analysis because Flegal was “a little bit plump herself.”the BMI-for-age chart used in most doctors' offices today is based on what children weighed between 1963 and 1994. a 1993 study by researchers at the United States Department of Health and Human Services titled “Actual Causes of Death in the United States.” the study's authors published a letter to the editors of the New England Journal of Medicine saying, “You [ . . . ] cited our 1993 paper as claiming ‘that every year 300,000 deaths in the United States are caused by obesity.' That is not what we claimed.”“Get in Shape, Girl!”The Fat Studies ReaderToo Fat for Chinaas I reported for the New York Times Magazine in 2019, it has become a common practice for infertility clinics to deny in vitro fertilization and other treatments to mothers above a certain body weightMichelle Obama 2016 speech, another speech, a 2010 speech to the School Nutrition Association, 2013 speechMarion Nestle, a 2011 blog postfood insecurity impacted 21 percent of all American households with children when Obama was elected TheHill.com story on SNAP“I could live on French fries,” she told the New York Times in 2009, explaining that she doesn't because “I have hips.”Ellyn Satter's an open letter to Obamaseveral other critiques of “Let's Move"“I don't want our children to be weight-obsessed"The Burnt Toast Podcast is produced and hosted by me, Virginia Sole-Smith. You can follow me on Instagram or Twitter.Burnt Toast transcripts and essays are edited and formatted by Corinne Fay, who runs @SellTradePlus, an Instagram account where you can buy and sell plus size clothing and also co-hosts mailbag episodes!The Burnt Toast logo is by Deanna Lowe.Our theme music is by Jeff Bailey and Chris Maxwell.Tommy Harron is our audio engineer.Thanks for listening and for supporting anti-diet, body liberation journalism! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit virginiasolesmith.substack.com/subscribe
Key Takeaways: Cancer Briefly Defined What Is a Tumor Cancer Cells VS Normal Cells Cells becoming Cancerous Cause of Gene Mutations Common Cancer Risk Factors BELIEVE IT ---Cancer is preventable Ways to Lower Your Risk The Importance of Weight Management A Closer Look at Inflammation The Gut Health Connection Amp Up Your Diet Cut the Booze Quit Smoking Get Moving The Value in Slumber Manage Stress Episode Summary: I am passionate about sharing this topic with people who are eager to ensure they reach and sustain optimal health! According to a study conducted in 2008 by M.D Anderson Cancer Center researchers, 90-95% of all cancer cases are due to lifestyle and environmental factors. As quick definition of Cancer refers to a group of related diseases where some of the body's cells become abnormal, begin to unceasingly divide, and eventually enter into surrounding tissues. This can start almost anywhere within the body. The abnormal cells that would have otherwise died off, survive, multiply, and initiate the growth of tumors. My hope is this YOUNGER podcast episode will exceed your expectations and help you feel well equipped with the knowledge, resources, and tools to arm you and your loved ones from cancer! Guest Bio: Dr. Robyn Benson is a Doctor of Oriental Medicine (DOM) who brings an innovative and game-changing approach to today's health care. Robyn offers the most advanced and cutting-edge therapies, procedures, and products designed to renew, restore, and revive health called A.R.T.: Amplified Regenerative Therapies. Dr. Benson, author, speaker, and self-care and Regenerative Medicine* expert, is known by many to be THE health detective with life-changing solutions! She has been the owner and founder of the Santa Fe Soul Center for Optimal Health (now Regenerative Medicine) for close to two decades. For almost 30 years, Dr. Benson has applied her considerable knowledge of acupuncture, platelet-rich plasma (PRP) therapy, herbs, IV therapies, and her love for healthy travel to help patients resolve acute and chronic health challenges and to achieve optimal and sustainable health without the use of pharmaceuticals or surgery. Resources for a Younger Lifestyle - Additional YOUNGER podcast episodes: https://robynbenson.com/podcasts/ Episode #88 - OutSmart Cancer® with Dr. Nalini Chilkov Episode #80 - The Truth About Inflammation with Dr. Robyn Benson Episode #55 - Eliminate Cancer Permanently! with Nathan Crane Episode #39 - Take Control of your DNA with Dr. J Dunn Episode #20 - Your Gut, Your Health, Your Wealth with Vincent Pedre, MD Episode #2 - Your Food, Your Health, Your Wealth with Terry Wahls, MD Additional resources used to assemble this episode for you: http://wcrf.org/int/research-we-fund/our-cancer-prevention-recommendations https://www.cancer.gov/about-cancer/understanding/what-is-cancer#drivers-of-cancer https://www.healio.com/hematology-oncology/news/online/%7Ba2bb4a67-dfab-41fe-8cf1-5536bf1c1655%7D/what-is-a-tumor https://www.verywell.com/cancer-cells-vs-normal-cells-2248794 https://www.mayoclinic.org/diseases-conditions/cancer/symptoms-causes/syc-20370588 http://thenatpath.com/blog/cancer-preventable-research-says-yes/ https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet https://www.ncbi.nlm.nih.gov/pubmed/24132111 https://www.ncbi.nlm.nih.gov/pubmed/24302613 https://theconversation.com/how-our-gut-bacteria-affect-cancer-risk-and-response-to-treatment-75699 https://www.health.harvard.edu/cancer/cancer-and-diet-whats-the-connection http://drhyman.com/blog/2015/08/07/5-strategies-to-prevent-and-treat-cancer/ https://link.springer.com/article/10.2165/00007256-200838040-00002 http://europepmc.org/abstract/med/14600545 https://www.cancercenter.com/community/newsletter/article/researchers-are-studying-the-link-between-sleep-and-cancer/ Quotes: “There is no safe level of tobacco use.” “Based on extensive research, there is strong scientific evidence connecting drinking alcohol with several types of cancer. According to the National Toxicology Program of the US Department of Health and Human Services, alcohol is listed as a known human carcinogen.” “According to the National Cancer Institute, obesity is one of the major risk factors for cancer.”
Peter Attia, MD, is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan.He is the host of The Drive, one of the most popular podcasts covering the topics of health and medicine.Dr. Attia received his medical degree from the Stanford University School of Medicine and trained for five years at the Johns Hopkins Hospital in general surgery, where he was the recipient of several prestigious awards, including resident of the year.He spent two years at the National Institutes of Health as a surgical oncology fellow at the National Cancer Institute, where his research focused on immune-based therapies for melanoma.Find out more about Peter Attia | WebsiteFor more stories and advice on founders and CEOs, head to alisacohn.comTo stay up to date on future episodes and learn more from Alisa, sign up for her newsletter.If you like what you hear, please subscribe to the podcast!Connect with Alisa! Follow Alisa Cohn on Instagram: @alisacohn Twitter: @alisacohn Facebook: facebook.com/alisa.cohn LinkedIn: https://www.linkedin.com/in/alisacohn/ Website: http://www.alisacohn.com Download her 5 scripts for delicate conversations (and 1 to make your life better) Grab a copy of From Start-Up to Grown-Up by Alisa Cohn from AmazonLove the show? Subscribe, Rate, Review, Like, and Share!
This week on Pharm5: Cost Plus Drug Co. adds Invokana products Gohibic (vilobelimab) EUA for COVID-19 Makena (hydroxyprogesterone caproate injection) withdrawn from market APL treatment oral tretinoin shortage Federal judge strikes down ACA's OCP and PrEP coverage Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Mark Cuban CostPlus Drug Company - Medications. http://bit.ly/3KjKYS5. Accessed April 6, 2023. Invokana® (canagliflozin) affordability. Janssen CarePath for Healthcare Professionals. http://bit.ly/3nWANLm. Published October 18, 2022. Accessed April 6, 2023. Center for Drug Evaluation and Research. FDA authorizes Gohibic (vilobelimab) injection. U.S. Food and Drug Administration. http://bit.ly/3nWDsVm. Published April 4, 2023. Accessed April 6, 2023. Gohibic [highlights of emergency use authorization]. Jena, Germany: InflaRx GmbH. Published April 2023. Accessed April 6, 2023. FDA Commissioner and Chief Scientist announce decision to withdraw approval of Makena. U.S. Food and Drug Administration. http://bit.ly/3ZMOY35. Published April 6, 2023. Accessed April 6, 2023. Drug shortage detail: Tretinoin capsules. ASHP. https://bit.ly/3KhQ2pT. Published March 20, 2023. Accessed April 6, 2023. Treatment of acute promyelocytic leukemia (APL). American Cancer Society. http://bit.ly/3mb3Nif. Accessed April 6, 2023. Cingam SR, Koshy NV. Acute Promyelocytic Leukemia. National Center for Biotechnology Information. http://bit.ly/3nGw5RV. Accessed April 6, 2023. Phillips C. Help Desk for Oncologists Treating People with a Rare Leukemia Pays Big Dividends. National Cancer Institute. http://bit.ly/40EtxT3. Published February 2, 2023. Accessed April 6, 2023. Braidwood Management, Inc., et al. v. Xavier Becerra, et al. Civil Action No. 4:20-cv-00283-O. Supreme Court of Texas, 2022. Accessed April 6, 2023. Judge strikes down Obamacare provisions requiring insurers cover some preventive care services. NBCNews.com. https://bit.ly/3MncZKV. Published March 30, 2023. Accessed April 6, 2023. Burwell v. Hobby Lobby and birth control. Planned Parenthood Action Fund. http://bit.ly/419fPaq. Accessed April 6, 2023. Stolberg SG, Abelson R. Federal judge strikes down Obamacare requirement for free preventive care. The New York Times. http://bit.ly/3nSSAU1. Published March 30, 2023. Accessed April 6, 2023.
2023 will be a big year for the Surveillance, Epidemiology and End Results (SEER) Program as it celebrates 50 years of using data to monitor trends and support research on the diagnosis, treatment and prevention of cancer. The SEER Program, which is funded by the National Cancer Institute, is making significant strides to decrease the burden of cancer through a suite of analytical tools that better capture data and make it more accessible to the research community. Steve Friedman, senior advisor for operations with the Surveillance Research Program in the Division of Cancer Control and Population Sciences at NCI, unpacks two new data initiatives, the Virtual Bio-Repository and the Virtual Pool Registry, that will allow researchers to collect additional clinical data and remove barriers for conducting multi-site cancer studies.
Brought to you by Wealthfront high-yield savings account, Helix Sleep premium mattresses, and Shopify global commerce platform providing tools to start, grow, market, and manage a retail business. Peter Attia, MD (@PeterAttiaMD), is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. He is the host of The Drive, one of the most popular podcasts covering the topics of health and medicine. Dr. Attia received his medical degree from the Stanford University School of Medicine and trained for five years at the Johns Hopkins Hospital in general surgery, where he was the recipient of several prestigious awards, including Resident of the Year. He spent two years at the National Institutes of Health as a surgical oncology fellow at the National Cancer Institute, where his research focused on immune-based therapies for melanoma.His new book is Outlive: The Science and Art of Longevity (3/28).Please enjoy!This episode is brought to you by Shopify! Shopify is one of my favorite platforms and one of my favorite companies. Shopify is designed for anyone to sell anywhere, giving entrepreneurs the resources once reserved for big business. In no time flat, you can have a great-looking online store that brings your ideas to life, and you can have the tools to manage your day-to-day and drive sales. No coding or design experience required.Go to shopify.com/Tim to sign up for a one-dollar-per-month trial period. It's a great deal for a great service, so I encourage you to check it out. Take your business to the next level today by visiting shopify.com/Tim.*This episode is also brought to you by Helix Sleep! Helix was selected as the #1 overall mattress of 2020 by GQ magazine, Wired, Apartment Therapy, and many others. With Helix, there's a specific mattress to meet each and every body's unique comfort needs. Just take their quiz—only two minutes to complete—that matches your body type and sleep preferences to the perfect mattress for you. They have a 10-year warranty, and you get to try it out for a hundred nights, risk-free. They'll even pick it up from you if you don't love it. And now, Helix is offering 20% off all mattress orders plus two free pillows at HelixSleep.com/Tim.*This episode is also brought to you by Wealthfront! Wealthfront is an app that helps you save and invest your money. Right now, you can earn 4.05% APY—that's the Annual Percentage Yield—with the Wealthfront Cash Account. That's more than twelve times more interest than if you left your money in a savings account at the average bank, according to FDIC.gov. It takes just a few minutes to sign up, and then you'll immediately start earning 3.8% interest on your savings. And when you open an account today, you'll get an extra fifty-dollar bonus with a deposit of five hundred dollars or more. Visit Wealthfront.com/Tim to get started.*[07:00] How and why Peter's muscle mass has increased significantly.[18:48] Why the long wait for Outlive: The Science and Art of Longevity?[23:19] Objective, strategy, and tactics.[28:50] From Medicine 1.0 to Medicine 3.0.[39:04] Randomized control trial results: guidelines, not gospel.[43:21] Revisiting why and how one should increase their medical literacy.[52:44] Avoiding scientific method misconceptions.[55:43] Austin Bradford Hill.[56:22] Observational study versus randomized control trial.[1:00:09] Are sleep trackers downgrading the quality of our sleep?[1:02:53] Under what conditions does Peter feel alcohol might be worth its downsides?[1:06:47] Continuous glucose monitors (CGMs).[1:18:24] Underutilized metrics and tools for expanding health and lifespan.[1:25:01] Strength.[1:33:11] Rucking around and finding out about VO2 max.[1:38:32] Finding the zone two sweet spot.[1:41:10] How skinning and rucking have upped my endurance.[1:42:24] Rucking vs. weighted vests.[1:46:39] Are neurodegenerative diseases preventable?[1:51:47] Helping your doctor understand and embrace Medicine 3.0.[1:53:47] How much is an ounce of prevention worth to you?[1:58:23] Early cancer screening.[2:06:33] Outlive chapters.[2:08:46] The chapter on emotional health that almost didn't make the book.[2:10:16] Peter's 47 affirmations.[2:14:18] Parting thoughts.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissPast guests on The Tim Ferriss Show include Jerry Seinfeld, Hugh Jackman, Dr. Jane Goodall, LeBron James, Kevin Hart, Doris Kearns Goodwin, Jamie Foxx, Matthew McConaughey, Esther Perel, Elizabeth Gilbert, Terry Crews, Sia, Yuval Noah Harari, Malcolm Gladwell, Madeleine Albright, Cheryl Strayed, Jim Collins, Mary Karr, Maria Popova, Sam Harris, Michael Phelps, Bob Iger, Edward Norton, Arnold Schwarzenegger, Neil Strauss, Ken Burns, Maria Sharapova, Marc Andreessen, Neil Gaiman, Neil de Grasse Tyson, Jocko Willink, Daniel Ek, Kelly Slater, Dr. Peter Attia, Seth Godin, Howard Marks, Dr. Brené Brown, Eric Schmidt, Michael Lewis, Joe Gebbia, Michael Pollan, Dr. Jordan Peterson, Vince Vaughn, Brian Koppelman, Ramit Sethi, Dax Shepard, Tony Robbins, Jim Dethmer, Dan Harris, Ray Dalio, Naval Ravikant, Vitalik Buterin, Elizabeth Lesser, Amanda Palmer, Katie Haun, Sir Richard Branson, Chuck Palahniuk, Arianna Huffington, Reid Hoffman, Bill Burr, Whitney Cummings, Rick Rubin, Dr. Vivek Murthy, Darren Aronofsky, Margaret Atwood, Mark Zuckerberg, Peter Thiel, Dr. Gabor Maté, Anne Lamott, Sarah Silverman, Dr. Andrew Huberman, and many more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
When you're searching for personal care products, whether a bar of soap or a bottle of lotion, are you reading the ingredients label? What harmful ingredients should be avoided? A recent study from the Journal of the National Cancer Institute found potential links between the regular use of hair straightening products like relaxers that contained "formaldehyde and formaldehyde-releasing chemicals," and uterine cancer, prompting a new federal lawsuit. There have been similarly troubling findings and lawsuits around some deodorants containing benzene, and powders containing talc contaminated with asbestos. Researchers at the University of Notre Dame found PFAS, sometimes called "forever chemicals," in 52% of cosmetics. Only a fraction of those products listed PFAS on the label. This hour, we hear from local makers who are focused on safe and natural ingredients. Plus, the Environmental Working Group has been building a searchable database of different products and ingredients for almost two decades, hoping to make it easier for consumers to shop smart. GUESTS: Melanie Benesch: Vice President of Government Affairs, Environmental Working Group Sami Jo Artus: Founder and Chief Beauty Maker, florapothecarie Mecca Davis-Provite: Owner, Rootuals Natural Hair Care Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.
Cytopathology Program Director Toolkit: Progressive Responsibility Dr. Vanda Torous, Chair of the ASC Cytopathology Program Directors Committee, interviews Dr. Sara Monaco and Dr. Armando Filie on their experiences with instituting progressive responsibility in their training programs in this episode of our series Cytopathology Program Director Toolkit. Dr. Monaco is a Professor of Pathology at Geisinger Commonwealth School of Medicine and the Program Director of the Geisinger Cytopathology Fellowship Program. She is on the executive board of the ASC and an associate editor of JASC. She has served on numerous ASC committees including serving most recently as the Chair of the Program Director committee and having spearheaded many initiatives in that role including the Unified Timeline for fellowship recruitment. Dr. Filie has been a faculty at the residency program in anatomic pathology and the fellowship program in cytopathology since he joined the Laboratory of Pathology at the National Cancer Institute, in 1996, and currently also serves as the director of the cytopathology fellowship training program at the Laboratory of Pathology, National Cancer Institute. Sponsored by the ASC Cytopathology Program Directors Committee.
Health equity and the Affordable Cancer Technologies Program are helping the National Cancer Institute achieve its mission of significantly lowering cancer rates around the world. NCI's Center for Global Health has adopted health equity as a core value to ensure that patients benefit from cancer research no matter their financial status as well as create opportunities for young people from low-income countries who want to pursue a career in cancer research. NCI also recently launched the second phase of the program to run until 2028. Center Director Dr. Satish Gopal said the program will commit up to $60 million to developing new tech and tools that will support global cancer control by improving cancer screenings and treatments.
Through his career in global health, Satish Gopal, MD, MPH, has called many places home, from Tanzania and Malawi to Bethesda, MD, where he now lives and serves as Director of the Center for Global Health at the National Cancer Institute. In this episode of the Explore Global Health podcast, Gopal shares his path into global health and how he carved out an impactful niche in cancer care and research in Malawi through the University of North Carolina at Chapel Hill's UNC-Project Malawi. He shares what it was like to embark on this career journey with his spouse and two young children by his side and offers career advice for students and trainees interested in making a difference in global health.
In this episode, creative technologist Roger Holzberg recounts his personal career journey from the Imagineering studio at the Walt Disney Company, where he devised and built original theme park rides, to his second career as where he applies immersive technology to health care and healing, first at the National Cancer Institute and now as a med tech innovator at Reimagine Well. Roger explains the subtle art of balancing new technologies with real world events and the ever-evolving customer experience. Discussion topics include: designing deep futures, the use case for virtual reality and augmented reality, dealing with animated dolphins, lessons from Walt Disney's Imagineering, visualization tech in cancer treatment and research, the use of distraction therapy, healthcare by design, teaching the art of world building, turning students in Imagineers, environmental sustainability. WEB SITE: https://reimaginewell.com/ Brett King is a world-renowned entrepreneur, futurist, speaker, international bestselling author, and media personality. China's President Xi Jinping cited his book Augmented: Life in the Smart Lane on the topic of Artificial Intelligence in his 2018 national address; the same book that was listed as a Top 10 non-fiction book in North America. In 2019 his book Bank 4.0 was awarded the Top Book by a Foreign Author in Russia for that year. Robert Tercek is an award-winning author, entrepreneur, and educator focused on the process of dematerialization and innovation. In his professional capacity, Mr. Tercek is a seasoned business executive with deep expertise in digital media and internet services. He is a prolific creator of interactive programs and products. He has designed and launched successful consumer experiences on every digital platform, including digital television, game consoles, broadband Internet, and mobile networks. In 2021, Mr. Tercek was recognized as the Humanitarian of the Year by the Media Excellence Awards for his leadership in designing and launching COVID SMART™, an interactive training program designed to keep workers safe on the job during the pandemic.
In this episode, creative technologist Roger Holzberg recounts his personal career journey from the Imagineering studio at the Walt Disney Company, where he devised and built original theme park rides, to his second career as where he applies immersive technology to health care and healing, first at the National Cancer Institute and now as a med tech innovator at Reimagine Well. Roger explains the subtle art of balancing new technologies with real world events and the ever-evolving customer experience. Discussion topics include: designing deep futures, the use case for virtual reality and augmented reality, dealing with animated dolphins, lessons from Walt Disney's Imagineering, visualization tech in cancer treatment and research, the use of distraction therapy, healthcare by design, teaching the art of world building, turning students in Imagineers, environmental sustainability. https://reimaginewell.com/
Eyes In The Sky: The Science Behind Modern Balloons This month, the news cycle has been dominated by updates about suspicious objects being detected in the stratosphere. This bonanza started with a balloon from China, and escalated as four more objects—not all confirmed as balloons—have been shot down from the sky. Although this might sound like a new problem, there are probably thousands of balloons floating above us—some for spying, others for exploring near space, or studying weather patterns. Dr. David Stupples, professor of electronic and radio engineering and director of electronic warfare research at City University of London, joins Ira to talk about the science behind modern balloons: how they work, what they do, and just how common they are. Low Income Patients Hit Hardest By Cancer Treatment Costs Being told you have cancer is not only terrifying, it's expensive. In the year following a diagnosis, the average cost of cancer treatment is about $42,000, according to the National Cancer Institute. Some of the newer cutting-edge treatments may cost $1 million or more. While insurance may cover some or all of that cost, many people are uninsured or under-insured. And the bills add up. A quarter of patients with medical debt have declared bankruptcy or lost their home, according to an analysis conducted by KHN and NPR. While there's been remarkable progress in treating cancers in the past several decades, less attention has been paid to just how astronomical the price tags can be. Researchers at Augusta University wanted to track the results of the financial burden after patients' treatment was complete. They found that poorer patients were hit harder financially—which not only resulted in more bills, but also worse health outcomes. Ira talks with Dr. Jorge Cortes, co-author of this study and director of the Georgia Cancer Center at Augusta University, about the importance of making cost part of the discussion in developing new cancer therapies. The Unseen World Of Seaweeds Chances are you don't give much thought to seaweed unless you're at the beach, or perhaps when you're considering a dinner menu. But the thousands of seaweed species around the world are a key part of our coastal ecosystems. Seaweeds photosynthesize, provide food and shelter for marine animals, stabilize the coastlines, and even contribute to making your ice cream creamier (through an ingredient called carrageenans, extracted from red seaweeds in the Rhodophyceae family). Increasingly, they're also being investigated as a source of biofuels and as biological factories, due to their fast-growing nature. Dr. John Bothwell, a phycologist at Durham University in the UK, has written a book in praise of seaweeds. In Seaweeds of the World: A Guide To Every Order, he highlights beautiful, unusual, and important species from each of the three seaweed lineages—green, red, and brown. In this segment, he talks with SciFri's Charles Bergquist about some of his favorite species, where the seaweeds fit into the web of life, and the importance of seaweeds to the global ecosystem. Why It Feels So Good To Eat Chocolate When you eat a piece of good chocolate, chances are you don't just bite down and chew away. There's a good chance you hold the chocolate in your mouth for a moment, feeling the silkiness as it softens, melting into a molten mass and mixing with your saliva. That gradual phase change process—as fats in the chocolate melt from solid to liquid—is a big part of the chocolate mouthfeel experience. Researchers at Leeds University in the UK have constructed an artificial tongue that doesn't focus on the taste of a food, but rather its texture, and how that texture changes over time. Using the artificial tongue, they explored the textures of materials that can change phase in the mouth, such as chocolate, butter, and ice cream. They reported their findings recently in the journal ACS Applied Materials & Interfaces. The researchers found that in dark chocolate, the sensation in the mouth is governed largely by the fat content, as the surface of the chocolate begins to soften. A few moments later, as the chocolate melts completely and mixes with saliva, the fat content of the treat is less important to the mouthfeel experience. Dr. Anwesha Sarkar, an author of the report, joins Ira to talk about the research, the challenge of designing a lower-fat chocolate that might exploit these findings, and the importance of learning about textures to determine why people like—and don't like—certain foods. Transcripts for each segment will be available the week after the show airs on sciencefriday.com.
For too long, women's health problems have been a mystery in the medical field. Often they are under-researched or just brushed off as part of the normal female experience. But with the help and expertise of our wonderful guest today, Dr. Andrew Goldstein, we are gaining massive insight and making large strides towards solving many of the issues that affect women's bodies. Dr. Goldstein is the Director of the Centers for Vulvovaginal Disorders and is currently a Clinical Professor at the George Washington University School of Medicine. On the show today, Dr. Goldstein chats with us about the plethora of research and clinical work he has done over the years on vulvar and vaginal pain. He discusses his diagnostic tool, his treatment options, and how a collaborative team approach can help catapult a patient's recovery. Dr. Goldstein is the Past-President of the International Society for the Study of Women's Sexual Health (ISSWSH). He is the founder and President of the Gynecologic Cancers Research Foundation. He has co-authored/co-edited 8 books, is actively involved in research and has published more than 150 peer-reviewed articles, abstracts, and book chapters on female sexual dysfunction, sexual pain disorders, lichen sclerosus, vulvodynia, vulvar vestibulitis syndrome (vestibulodynia), and cervical cancer. He has lectured extensively on the subjects of vulvodynia, vulvar disease, and female sexual dysfunction, and has been interviewed by many media outlets and publications including 20/20, The View, Dr Oz, Good Morning America, Katie, Dr. Drew, The Discovery Channel, BBC, local affiliates of CBS, NBC, ABC, and Fox, New York Times, Washington Post, Allure, Cosmopolitan, Essence, Women's Health, and Prevention.Dr. Goldstein has a strong commitment to global medicine and in 2015-16 spent a year in South America and South-East Asia volunteering, along with his family, with 11 different NGO's providing medical care. He frequently travels to rural China, Cambodia and Peru where he is collaborating with the National Cancer Institute to develop a rapid, high-volume, and low-cost cervical cancer screening protocol. Connect with him:www.vulvodynia.com Buy his latest book:https://www.amazon.com/When-Sex-Hurts-Understanding-Healing-ebook/dp/B09ZB714DQ?ref_=ast_author_mpbResources:https://www.isswsh.org/
While many would think art and science are two vastly different disciplines, one common driver often motivates them both – curiosity. Ginny Ruffner – who currently has a retrospective exhibition open at the Bainbridge Island Museum of Art on the topic of “What if?” – has worked at the intersection of art and science for decades. Her curiosity around biological concepts has propelled her to invent answers to “what if?” questions about the nature of the world around us. The experimental works she creates often involve the use of technology and mixed media to create new and imaginative experiences. Her creations are fueled by collaboration and camaraderie with scientists such as ISB President Dr. Jim Heath. Join us in person at Town Hall Seattle for a conversation with internationally renowned artist Ginny Ruffner and ISB President Dr. Jim Heath. Together, they will explore the opportunities and striking similarities that lie at the intersection of art and science. Ginny Ruffner is a pioneering American glass artist based in Seattle. She is known for her use of the lampworking technique and for her use of borosilicate glass in her painted glass sculptures. Many of her ideas begin with drawings. Her works also include pop-up books, large-scale public art, and augmented reality. Ruffner was named a Master of the Medium by the James Renwick Alliance in 2007. She received The Glass Art Society's Lifetime Award in 2019. Ruffner currently has a retrospective exhibition open at the Bainbridge Island Museum of Art on the topic of “What if?” Dr. Jim Heath is President and Professor at Institute for Systems Biology in Seattle. Heath also has the position of Professor of Molecular and Medical Pharmacology at UCLA. Formerly, he directed the National Cancer Institute-funded NSB Cancer Center, was the Elizabeth W. Gilloon Professor of Chemistry at Caltech, and served as co-director of the Parker Institute for Cancer Immunotherapy at UCLA until 2017. Presented by Town Hall Seattle and the Institute of Systems Biology. Our community partner for this event is the Bainbridge Island Museum of Art.
In this explosive episode, we dive deep into the craziest string of events that we have witnessed in our lifetime. From the shocking train derailment in Ohio that caused a radioactive mushroom cloud, to the two other derailments in Texas and North Carolina carrying toxic chemicals that the media is barely covering. But that's not all. We also explore the four unidentified flying objects that have been shot down by the Biden administration, including one that was over Lake Michigan and evaded the first missile strike. Is this the government hiding the truth about extraterrestrial life, or is there something else going on here? We also examine the recent discussions surrounding Epstein's list being released, as well as other topics that have been hidden from the public eye. The coincidence between a movie that was recently released and the Ohio train derailment raises many questions and fuels conspiracy theories. We bring you the facts and let you decide. Subscribe and leave a 5-star review! ----more---- Donate to support the show by going to https://givesendgo.com/redpillrevolution Our website https://redpillrevolution.co/ Podcast Companion: https://redpillrevolution.substack.com ----more---- Full Transcription Subscribe and leave a 5-star review! ----more---- Donate to support the show by going to https://givesendgo.com/redpillrevolution Our website https://redpillrevolution.co/ Podcast Companion: https://redpillrevolution.substack.com ----more---- Full Transcription Welcome to the Revolution. Hello and welcome to Red Pill Revolution. My name is Austin Adams and thank you so much for listening today. This is a wild time to be alive, and we're gonna find out, uh, just how wild today as we are going over some of the craziest string of events that I've ever been. Witness to in my entire life. And I'm sure at least majority of the people here, unless you were alive, maybe during, I don't know, the forties. Uh, this is so crazy. So we're gonna jump right into it. Today, we are going to be discussing the recent string of events, everything from the train derailment in Ohio, causing almost nuclear type of radioactive waste, a huge mushroom crowd cloud, basically. This city in Ohio due to this train derailment, which has gotten basically no coverage, very little if not any coverage at all from the mainstream media as to actually how bad this truly is. It's, it's, when you see the pictures of this, it's horrifying. On the back of that, today, there was two other trains that were derailed. One in Texas and one in, I believe, North Carolina, one of those also carrying. Toxic chemicals. Hmm. Now we are also going to follow that up with four different unidentified flying objects, which have been shot down in the last week alone by the Biden administration in the United States military, including one of the time over Lake Michigan, in which the very first missile strike actually missed. Which makes things a little bit more interesting because I don't think , I don't think China's balloon had the capabilities to do that, so that makes it that much more interesting. The White House responding specifically to the questions surrounding is this aliens, which we will look at the White House pl uh, press Secretary responding to. Then we are going to touch on the recent. Uh, discussions surrounding Epstein's List being released, as well as a few other things. So make sure you stick around. Today's gonna be a crazy episode. We are also going to look into a pretty unbelievable, well, it would seem unbelievable if you didn't actually listen to it with me, but this coincidence, coincidence between a movie that was released and the recent train derail. Yeah, that's all I'm gonna say for now. But it's a crazy, crazy coincidence, which is fueling many, many conspiracy theories surrounding all of this. So all of that and more. But first, I need you to hit that subscribe button. I need you to leave a five star review, okay? When you hit that five star review button, I would appreciate it from the bottom of my heart. Just know that I'm giving you a virtual. Hug, high five, fist bump. However you roll. I'll do it for you so it's there as soon as you do it. Five star review, if you could just write something up in there for me, it would help me get up in the rankings, help the podcast to grow, and I would appreciate it. Head over to the red pill revolution.dot com. Every single week, you will get a podcast companion sent directly to your email along with several articles about the things that we discussed directly into your email, including the links from the video or links from the podcast. The full video podcast. The audio podcast, the clips that we pull from each one of them. So you can look at just at the specific topics that we're discuss. All of it and more directly in that ck red pill, revolution.ck.com. It is free to sign up. There's a link at the bottom if you would like to become a paid subscriber, but there's nothing below it other than another virtual hug and appreciation un underneath that. So, um, I appreciate you guys so much. Without further ado, let's jump into it. Welcome to Red Pill Revolution. My name is Austin Adams. Red Pill Revolution started out with me, realizing everything that I knew, everything that I believed, everything I interpreted about my life is through the lens of the information I was spoonfed as a child. Religion, politics, history, conspiracies, Hollywood medicine, money, food, all of it. Everything we know was tactfully written to influence your decisions and your view on reality by those in power. Now I'm on a mission, a mission to retrain and reeducate myself to find the true reality of what is behind that curtain. And I'm taking your ass with me. Welcome to the Revolution. All right. The very first thing we are going to jump into today is the Ohio train derailment, which is resulting in lawsuits, dead animals, like schools of fish being floating down the river dead as a result of all of the toxic chemicals that have been released. From this train derailment, and again, there's very, very little media coverage, if any at all actually happening here. And when you look at these pictures, I cannot fathom living in this town. I, I cannot believe they have not completely told everybody to leave. It's, it's horrific to actually look at it. It looks like a nuclear event when you, the, the whole sky has turned black around this city. There's a huge, like almost mushroom cloud that came up as a result of this. And so let's, let's go ahead and read this article. We'll talk about some of the things that are going on here and see if we can tie some of them together, because it gets quite interesting. All right. Now this article is coming from Yahoo. And it starts by saying that the tr, the Ohio train derailment results in lawsuits, dead animals, and lingering questions about toxic chemicals. And this was written on February 13th. All right. It says, the follow continues from the derailment of a train carrying toxic chemicals near the Ohio Pennsylvania border earlier this month as local residents file lawsuits and some cast out in official assurances about air and water quality. Now, as a side note, this Ohio River that this happened around. Fund, like basically gives 10% of the United States their drinking water. So an obvious concern for many, many people in the Midwest area. This says on February 3rd, 50 train cars operated by Norfolk Southern, uh, southern derailed in the East, pales Palestine, Ohio. A town of about 5,000 people located 50 miles northwest of Pittsburgh. Now, keep that in mind as we go on in this episode, that there's only 5,000 people in this. Only 5,000 people. It's not a very big town. That Derailment. Derailment resulted the name massive fire in government, Mike DeWine ordering an evacuation. So it has been evacuated since February 5th. Within the last two hours, a drastic temperature change has taken place in a rail car, and there is now the potential of a catastrophic tanker failure, which could cause an explosion with a potential of deadly shrapnel traveling up to a. DeWine said in the statement, adding that those with children in their home who choose not to evacuate would be subject to arrest. Whoa. Last month, a Norfolk Southern released toxic chemicals from five of the derailed tanker cars. In an attempt to preempt a larger explosion, one of the chemicals they were most concerned about was vinyl chloride. A colorless gas used to. Plastic products according to the National Cancer Institute, exposure to the gas is associated with an increased risk of rare form of liver cancer, as well as primary liver cancer, brain and lung cancers, lymphoma and leukemia. Wow. And that is what they're making plastic. Products with, Hmm. Maybe not something that we should be ingesting in the first place. Um, but obviously even more concerning if it's just leaking into the air around you. Concurrent with the releasing of the chemicals, DeWine and Pennsylvania Governor Josh Shapiro issued a wider evacuation order for the area around East PA Palestine stating the controlled release process involves the burning of real car chemicals, which will release fumes into the air. That can be deadly if. Based on current weather patterns, the expected flow of the smoke fumes, anyone who remains in the red, effective areas facing grave, danger of death, anyone who remains in the yellow impacted areas at the high risk of severe injury, including skin burns and serious lung cancer or lung damage. Two days later, DeWine issued a statement that it was safe for residents to return home saying, yeah, no thanks. Air quality samples in the area of the wreck and the nearby residential neighborhoods have consistently showed readings at it points below, safety screening levels for contaminants of concern. Based on this information, state and local health officials determined that it is now safe for the community members to return to the residents. Now, this is a decently long article, um, but we get the gist of. Right. That's horrific, right? Horrific. 5,000 people in this town and how many in the surrounding areas that are having to leave because of a controlled release of these chemicals, these toxic, toxic chemicals, which according to them, if you're even around that area, will kill you. And if you're close to the area around that area, you might just die slowly. and very, very little news coverage. And again, if you look at the pictures of what is out there and what this looks. I, I would never want to go back to that home of mine again. I can't imagine bringing my children into that house after all of those toxic chemicals in the air. You think they're just gone. You think they didn't just settle like people are relating this to trenoble levels of nuclear waste is what they're relating this amount of chemicals to in this town of Palestine. So what makes this even more interest? Is that today, February 13th, there was two more trained derailments, two more trained derailments, one in Texas and one in South Carolina, one of those trained derailments carrying hazardous materials. So this as a train has derailed in the Houston area. This comes from citizen free press official reports. The train was carrying hazardous materials, prompting union specific to monitor air quality in the site crash according to Splendora Police Department. What are the odds? Now? It says hours later, a train derailed and then enroll. In or in Orrie, in Orrie, South Carolina on Monday with no reported fatalities. And CSX Transportation, which owns derailment is a site along the emergency cruise. Now, one thing I'd like to go back on in the original thing, um, the original derailment was that it was the result, if I'm not mistaken here, maybe it was one of these other ones, but one of them was the result of a semi. Okay. A semi-truck ran into one of them. Let me double check on that. But let me see here if semi-truck, and let's go get Palestine, because I believe, and this this comes into play in just a moment when we took, get into the actual specifics of why there's so many, uh, conspiracy theories surrounding this in some weird, like, not even weird, but unbelievably crazy, crazy. Coincidences, if you would like to call them that, which is sparking a lot of people to question whether this is, you know, intentional or not. When we have multiple things like this happening all at once. All right? Now I'm not seeing specific. Okay, so here this is, this is it. It was from a different one. So one of the Houston and uh, or South Carolina one. So it says the crash by the 18 wheeler and union specific train occurred shortly before 7:30 AM Monday along Interstate 69, US 59 nearest intersection with poria and midline roads. So that was from a 18 wheeler semi-truck. All right. The one that was in. Now again, keep that in mind when we continue this conversation in just a minute. But before we do that, let's go ahead and read here. Um, it says, meanwhile, transportation Secretary Pete Buttigieg talked about equity in the construction industry on Monday and didn't offer any remarks at all about the recent train derailment in the Eastern Pale Palestine. I don't know if it's Palestine or Palestine, I'm pretty sure it's Palestine. Uh, so the very, very silent on this from the White House, very, very silent on this from our news media, mainstream media, corporations. The only people that are really reporting on this are people who are on the ground right now. Some reporters who reported on this, and this is where it gets a little bit weird. A reporter was arrested during a news event about the Ohio trained derailment arrested. And this says, A reporter was pushed to the ground, handcuffed and arrested for trespassing while covering a news conference about the derailment of a train carrying toxic chemicals in Ohio. News Nation posted a video of correspondent Evan Lambert being arrested Wednesday in the gymnasium of an elementary school in East Palestine, where Governor Mike DeWine was giving an update about the incident. Lamber Lambert was held for about five hours before being released from jail. I'm doing fine right now. He said it's been an extremely long. No journalist expects to be arrested when you're just doing your job, and I think that's really important that it does not happen in our country. Yeah, well, it shouldn't unless he was doing something that we haven't read yet. But there is something called the freedom of press at the end of his news conference. DeWine said he didn't authorize the arrest, and reporters have every right to report during briefings. Yes, they do. If someone was, excuse me. My goodness. Might, might have been some of those trained chemical. All right. If someone was stopped from doing that or told they could not do that, that was wrong. A following statement from the governor's office said DeWine didn't see the incident because of a bank of cameras blocked his view, but he did hear a disagreement towards the back of the gymnasium. DeWine has always restricted the media's right. Who? Yeah. Screw off. Um, Mike Aria, news Nation's, Washington, and post bureau chief called the Arrest and Infuriating violation of the First Amendment. The Washington DC based Lambert could still face charges of disorderly conduct and criminal trespass. News Nation said the Columbiana County Sheriff's Office Administration said the arrest was made by officers. Uh, a message seeking comment from the department was not immediately returned. Now this goes on to explain what happened, um, with the actual train derailment, which we've already read. It says The news conference started more than two hours late into wine. Started speaking at the same time, same instant. Lambert had to do a live broadcast from the back of the gym. Ger said police officers approached Lambert and asked him to stop talking. Lambert finished the live report, but was then asked to leave by authorities who tried to forcibly remove him from the event. From their standpoint, uh, he did not obey orders. Gymnasiums are echoy and loud, and so sound kind of carries, so I'm guessing that they just didn't like the fact that there was sound competing with the governor speaking, even though it was all the way at the other end of the. The anchor handling the report said he, she heard the reporter saying, the governor has just started speaking. I'm being told that I have to quit my report. Before it was cut short, he was then taken outside and placed in the back of a Sheriff's patrol car. Weird. So one of the only news networks from W K B N tv, uh, which is who captured the video of him being put on his face, on the ground and being handcuffed. Had the, one of the reporters while the news, uh, news Nation Reporter, which is who he was associated with, arrested for even trying to talk about this, even trying to be there and have a discussion around this. He was arrested by sheriffs. Now let's look at one more coincidence when it comes to the trains, which is. There is a movie with Adam Driver as the lead, which was shot in Palestine, Ohio, about a train that derailed releasing toxic chemicals in causing a max exodus of the public to get away from the Deadly Fumes. A Hollywood movie on Netflix right now called White. What can, can you look at me in the eye? Look me in the eye right now and tell me that's a coincidence, cuz I don't think you can do it. , this says that social media users are pointing out the Netflix movie, white Noise Starting Actor Adam Driver has eerie similarities to a catastrophic train derailment that took place earlier this month in. The movie based in Ohio in the 1980s depicts a college professor in his family, forced to evacuate their homes after a nearby train. Derailment prompts an airborne radiological event. Parts of the movie, which D debuted last August were filmed near East Palestine. The sites were 50 train cars derailed 10 days ago. Spewing toxic chemicals with citizens of the town, incredibly appearing in the movie as extras. What, what , so here's a quote. It says, here's a movie they just made about, just made about a train derailing with toxins in Ohio, filmed in Ohio, where this just happened. And many of the extras were locals from East Palestine, Ohio, who in the film evacuated. Then months later, just months later, they had to do so in real life. Now, if that is not a part of this simulations programming or a little glitch in the matrix, I don't know what is. And if it's not, it's all intentional and there's much more sinister things going on. But, uh, I think the easier path of least resistance here is just assuming we're in the matrix. Says the similarities between the movie and the actual event were so bizarre. Even CNN published an article on the coincidence interviewing a East Palestine resident who played a background actor. When Ben Ratner's family signed up in 2021, as said to be extras in the movie White Noise, they thought it would be a fun distraction from their day-to-day life in the blue collar East Palestine, Ohio. Ratner 37 is in an intense traffic jam scene sitting in the line of cars trying to evacuate after a freight train collided with a tanker truck triggering an explosion that fills the air with dangerous toxins. Now that's what I'm talking about, where one of these train derailments actually happened because there was a semi-truck that ran into it, and in this very movie, which was based in Ohio using Palestine reside. The train was derailed by a semi-truck. Can you look me in the eye and tell me that that's a coincidence? I don't think you can. The 20 20 20 22 movie was shot around Ohio and is based on a novel by Don DeLillo. The book was published in 1985, short teen, or shortly after, a chemical disaster in India that nearly killed 4,000 people. The book and film followed the fictional Gladney family, a couple and their four kids, as they flee an airborne toxic event and then return home and try to resume their normal lives. All of a sudden, they hit too close to home. The father said. The mysterious parallels between the movie in real life come as a Norfolk Southern Railroad train. Traveling from Illinois to Pennsylvania derailed in the massive fiery disaster on February 3rd with five train cars carrying noxious commercial compounds like vinyl chloride, which is known to cause cancer officials ordered mandatory evacuations of nearby areas and controlled releases of some of the toxic. Compounds since then, animals nearby as far as 10 miles away have been D developing illnesses and dying from the toxic chemicals that contaminated the area. Despite health issues, animals are exhibiting, officials gave the all clear for residents just five days later. Whoa. Let's go ahead and watch this trailer with Adam Driver. If he gets to be louder annoying, we'll, we'll stop it, but I don't think it will be. Um, but let's go ahead and listen to this. And you can hear this trailer from this movie about what just exactly happened, uh, in the programming of the matrix. Here we go. You like that protein? That stuff causes cancer in laboratory animals. In case you didn't know either a chew gum or a smoke. All these children, yours, that's mine from wives one and three. There's fe bets from Husband two. Wilder is ours. We're each other's force. I hope it lasts forever now as a semi truck is running into a train and then it exploding. Let's watch a sitcom or something. No, they're calling it the Airborne Toxic Event. We. Will we have to leave our home? Of course not. How do you know? I just know. Okay, what if it's dangerous? We have a situation, miles. All we have to do is stay out of the way. They're passing this tab. Technically, that's illegal. Do she have lashes on script? Now, this was up for an Academy Award, by the way, father, we're going sideways. Dad, do sheep have lashes? Doesn't anyone wanna pay attention to what's actually happening? What's a bunch of people in hazmat suits walking around? There are two kinds of people in the world. Most of us are dire right now. We're safe as long as the children are here. Us for some persistent sense of large scale ruin. We keep inventing. Looks a little murdery towards the end. So yeah, that's one of the craziest, if not the craziest coincidence to happen that I've seen almost ever. There's no way. No. How many, how many cities are there in the United States of America? Let's just cut it off there. There's a 2% likelihood that it happened in Ohio. 2% now in Ohio. How many cities are there, let's say, A thousand cities in Ohio. There's probably more, maybe I'm wrong, and there's less. Let's say there's 500, there's a thousand cities in Ohio. Let's say a thousand. That means there's a point, am my mask gonna be wrong here? Zero, zero 2% likelihood that it happened in this city, in this state. Then let's get into the likelihood of the timeframe within a year of this movie being put out. Then we talk about 0.0002 going to point, I don't know, call it 150, 300 years that you wanna play that timeline where trains could get ran into maybe by semi trucks, maybe the last 50. So even call it the last 50 , whatever this math is doing, it's a wildly unbelievable statistic. Or that this happened in this way. There's no statistical probability that this actually occurred in this manner. in the same place as this movie where it occurred in this manner. No way at all. Okay, number one weird thing going on at this very moment. Okay? There's the first thing. All right? Now the next thing that we're gonna get into is the military in the Biden administration. The United States of America has shot down four unidentified flying objects in just the last. Now one of those happens to be a silly looking white balloon that was floating over, and we'll talk about why I think that's interesting in just a moment. But three of those other ones, including one that was shot down today in over Lake Michigan, were not, they were cynical. iCal . So our White House actually spoke out about this and said, and was asked the question, are these aliens? So we'll watch that in just a moment, but let's go ahead and read this article first. But the White House actually spent the afternoon telling reporters. That they shouldn't be worrying about an alien invasion that just happened. Okay, so in a truly bizarre turn of events, press Secretary Korean Jean Pierre, addressed the downing of three unidentified objects in the past 48 hours by US Jets. Using the phrase, there is no indication of aliens or extra trio activity with these recent takedowns. There's no indication. , which means not yet. Anyways, Jean Pierre added that. She wanted to make sure the American people knew that. All of you knew that. And it is important to say that from here because we've been hearing a lot about it. Oh, have you? Of course you have. And, and, and that's where we're talking about these little sprinkles, right? Sprinkles. All of a sudden UFOs are gonna be something the government's been talking about. And we did a whole episode, I don't know, 20, 30 episodes ago, about Project Blue. If you don't know what Project Bluebeam is, we'll talk about that in just a minute. So let's address this first, but that is what a lot of people seem to be thinking is that between, there's a lot of things that have been released lately in the last week and a half, two weeks. There's a lot of really big news that is going to be breaking upcoming from the Epstein documents to a self-admitted black or black flag. Event, which happened, well, maybe not black flag, but, um, a false flag and not a false flag either. a, a event Biden administration admitted to basically blowing up the Nor Stream pipeline. So we'll see how that ties into it in just a minute. But let's go ahead and listen here to what the press Secretary has to say about u. Make sure we address this from the White House. I know there have been questions and and concerns about this, but there is no, again, no indication of aliens or extraterrestrial activity with these recent takedowns. Again, there is no indication of aliens or terrestrial activity with these recent takedowns. Wanted to make sure that the American people knew that all of you knew that. Uh, and it was important for us to say that from here because we've been hearing a lot about. because you guys have been telling us the stories about them. why would you not be hearing about it? Um, and also how would you be able to tell us if it was aliens or not, right? Um, she also said, uh, would you tell us if it was aliens? And she responded, I'm not. I love et the movie, but I'm just going to leave it there. With all seriousness, I know there are a lot of questions about the flying. So she didn't answer that question. The press secretary then handed over the National Security Council spokesman, John Kirby, who did say, I don't think the American people need to worry about aliens with respect to these crafts, period. I don't think anything else needs to be said there. My understanding is that, uh, the top officials in the Pentagon when asked explicitly if, uh, they were ruling out any kind of extraterrestrial presence, that they weren't ruling anything out. And yet at the beginning of today's, Albeit with her usual winning smile, uh, Ms. Jean Pierre seemed to rule out any extra terrestrial activity. I don't think the American people need to worry about aliens with respect to these craft period. I don't think there's any more that needs to be said there on the, what's important about the way that he phrased that is I don't think the American people need to worry about aliens. Not that these aren't aliens, not that these are not extraterrestrials, not that we know 100%, that this is not the. What he said was, I don't think the American people need to worry about aliens with respect to these crafts. So two parts of that linguistic programming for you there I don't think is a passive statement. Not, I know. I don't think the American people need to worry. About aliens with respect to these crafts. It's all in how you say it, right? He says, I don't think the American people need to worry about aliens with respect to these crafts. But he could have said in the same words, I don't think the American people need to worry about aliens with respect to these crafts, period. The same statement can be said with different tonality, with the words that he said. It doesn't matter when you look at the words. He's not ruling it out. He's not saying, no, absolutely not. These are not aliens. Absolutely not. These are not extraterrestrials and some people are believing. Again, getting back to the, the. Overarching, ID like conspiracies surrounding this right now. Some people think that they're actually programming the, the general public to believe that that's what is going on here, because that's how it would appear, right? There's not too many press secretary meetings with the White House, where you have not only the Press Secretary, but also the, you know, str, white House National Security Council, strategic Communications coordinator, John Kirby, also coming out and talking about aliens because they shot down ufo. That is what's happening right now in the United States of America and in the world in 2023. In three years, five years, 10 years ago, uh, you were called crazy for talking about the aliens. , like it was actually a possibility, right? It says, speculation over the objects was running rampant over when they were described by military officials as metallic and balloon like with some reports indicating that they have no identifiable propulsion systems and have even interfered with equipment and military jets that got close to them. Glenn Van Herrick and Air Force General who commands NORAD and US Northern Commands was asked whether the Pentagon was ruling out aliens regarding the objects and replied, I haven't ruled out anything at this point. We will continue to. Every threat questions are being asked about the complete lack of details on the objects, um, on what they are, and the fact that Joe Biden hasn't even commented on the takedowns, and here he is completely ignoring the questions. Mr. President, do you object? Were you to, was it a balloon, Mr. President? Okay. I mean, that's useless. She's literally 70 yards away screaming, so I can't imagine he could hear somebody five fr from him with his hearing aids. Probably as low as they are, let alone as far as this reporter was. So I, I would take that with a grain of salt. Um, now, Rand Paul tweeted, uh, as ranking member of the House Homeland Security Committee, I demand the president of the United States and Department of Defense tell us what they know and what they don't immediately. And that was today, this morning. Kirby claims, the Biden administration has been transparent as we can be, and that's where he stands in this statement here, because it's so unprecedented. Um, should the public be hearing from the president directly on this? I have. We, we have been, uh, uh, I think as transparent as we can be. I, I won't speak for the president's, uh, uh, personal, uh, speaking schedule, but I mean, he has been deeply engaged. Uh, every one of these decisions, he's been kept informed, including as of this morning on uh, what's going on with recovery efforts. Um, and, uh, and, uh, he's very much staying on top of the issue and, uh, and directing his team to make sure we are properly consulting and briefing, not just members of Congress, but state leaders as well. And of course, you know, we're also doing what we can in the, in the public sphere. All right. Again, not saying anything about what's actually going on there. Okay. Um, so time will tell and maybe it won't. Right. A lot of people are alluding, so let, let's, let's look at both sides of this. Okay. Let's take the train derailment out of it. Let's take everything else around it. What I have an issue with here is that initially we were dealing with a Chinese spy. A week ago, this whole huge media presence around the spy balloon, this white blip getting a missile thrown at it and falling down to the sea for days. We tracked this. It was this whole huge ordeal where it was all immediate. People were questioning why it came out about it being Chinese spy balloon. How did we know it's a Chinese spy balloon? How do we. Okay. So that's something to me that you have to take into consideration with these other three objects that have now been shot down, which they said were not the same thing as we shot down before. This was not a Chinese spy balloon. The other three objects, they were the, the spy balloon was not metallic, it was not cynical. Right. So what I think is weird is that. Putting out there, the, the idea initially before these types of weird shot down UFOs happened, the idea they were putting the idea out there to program the general public into thinking that it was also going to be Chinese technology. Right? They were, they were putting the idea out there heavily for days, preempting us moving into this event where we had three UFOs get shot down that were metallic, evading. Missiles and causing disruptions in radio frequencies from our fighter jets that were scrambled toward. Like F 20 twos, like that's not low technology for what we have. So that's one thing that I find to be weird about the whole thing. Just, just looking at it as a whole, I find it weird that we were being programmed to believe that there was a Chinese spy balloon, Chinese spy balloon, Chinese spy balloon, Chinese spy balloon. Now, there's three other objects that have been shot down since, and nobody's talking about them in the same way that they were the Chinese. Why are we not as interested in U F O potential extraterrestrial aircraft, which were shot down by F 20 twos as we were about a floating balloon from the big bad China man, right? Why? Why are we not as up in arms? Why is there not as much footage? Why is there not as many tweets going out there? Why? Why is this being suppressed in the way that's different? Why is the president not speaking out about it because he was speaking out about the Chinese balloon within a day or. I find that to be weird, right? Let's, let's keep Epstein out of this. Let's keep the train derailments. Let's keep the fact that the Nord Stream pipeline was blown up by the United States against Russia and admitted to it. Let's keep out the idea of, you know, everything else. I find that to be weird. Now. Everything that I just mentioned also happened in the last week, right? So there's that. Um, there was a pretty good tweet that was sent out by DC Drano, as always. Um, which said something along the lines of this, he said In the past week we've had three major train derailments, including one with a chemical spill. Four flying objects shot down by our military. Every major social media platform went down at the exact same time in, went out in two congressional buildings. I have to ask, are we. Attack. He said, what are the likelihoods that all of those things are happening simultaneously along the same timeframe that we're finding out that the Biden administration blew up the Nord Stream pipeline, you know? Basically starting at the very beginning of this war and putting us in a position to where the United States may have to defend itself against a world superpower because Biden, the big man hisself, was trying to protect the investment assets of his son at Barisma. So let's see what else they have to say about it. , but actually, let's go back because what, what if, what if we are under attack? What, what, who, who, who at this point would, would that be from, right. If we're finding out that the North Stream pipeline was blown up by the United States, which we kind of all knew already, right? We all kind of knew that. But it being finally put out there that that was actually what happened. Now we have a huge chemical spill leaking into the water systems of the everyday Americans. Now we have four incidents. Where we have to scramble fighter jets over us airspace to shoot down UFOs. All social media companies went down simultaneously at the same exact time, and two congressional buildings lost power at the same time as well. What are the odds of all of that? And, and, and, and here's the other thing that I'm seeing. I'm seeing prominent special forces guys like Mike Glover, like Tim Kennedy sounding the alarm on all of these things that are happening, telling you to get ready. Okay, I'll, I'll read you what Mike Glover said here. Um, and if you don't know about Mike Glover, let me pull up his account and see what his credentials are. Um, or if it'll even say, uh, but as far as I know, he was some type of, you know, tip of the spear Special forces. Uh, American War Hero and, uh, what he said was this, if I was the enemy, I'd create distrust in people and institutions through social media sabotage and burn supply chains, spy on key infrastructure and defense, and distract everyone away from the real intent Before I struck. Thank God none of that would ever happen here. Now, he had some people commenting on his post as. Um, saying, man, this feels a lot like it's very easy to conclude what that means, right? Shaping the general public's opinion. A slight of hand position between one to the other. I'm trying to show you what's going on, like kind of the old, look at this, look at this. I got this left hand here, and then poof. Hit you with the right is what I assume they're talking about, right? Shaping the general public's opinion, um, and getting you to to look one way while something else is going on in the other. And, and if this was going to happen and we were preempting, you know, the same way that we took some type of action on the Nord Stream pipeline, what if Russia was taking these actions? These types of things, like the UFOs situation, maybe they have drones up there. Um, maybe they were the ones that are carrying out these hazardous material train attacks. Um, maybe, maybe, maybe. I'm not saying that's the case, but it just seems like an awfully weird coincidence, especially when you have all of these ex-military guys seeming to pick up on the idea that this is some type of military operation. Right. Lots and lots of them are talking about this. Okay. Um, so let's move. All right. There's another article here that talks about it, which says The US military's first shot at unknown OC Octa octagonal object over like Huron Mist official said, which is pretty bizarre. Here's the clip. Uh, let me get a couple other folks here, Mike, and then. That, uh, the only reason the American people know about the first balloon is cuz a couple of guys in Montana spotted it and, and, and it leaked out. My, my question is, if it had remained secret and had not become a spectacle and be, and arguably an embarrassment to the White House, would you have shot it down or allowed it to continue on its way? So you're asking me to speculate? Sure. you like, so, so Mike, I, I'll kind of just push back a little bit at, at the assertion there. Uh, so first of all, again, what made this balloon different was the length and duration, uh, that it was over the United, the continental United States. Look, we track activities all over the globe on a daily basis. Um, Some of which will remain classified because again, we don't wanna reveal sources and methods in this particular case. Um, I can tell you, uh, that there were efforts underway to, uh, to make that public. Um, I, you know, Montana journalists reporting notwithstanding, um, all that to say, look, there are gonna be times when there's activities happening that we're monitoring that we're, we're not gonna go public, especially if it. Present a particular or pose a significant threat to the American public. Um, but again, uh, as, as we monitored that balloon, uh, there was an effort underway to ensure that that folks understood what this was, especially given how visible it was. Um, and I'll just stop there. Thank you. All right, so this article goes in to say that the US military jet that downed an unknown object in the Michigan sky on Sunday, missed on its first attempt over Lake Huron officials told Fox News the Air Force Ethics F 16 jet used using a Sidewinder missile to attack the target. The first side winder heat seeking missile missed the target. Uh, it goes honestly, it wasn't clear whether the missile that missed ultimately, , where are the missile that miss ultimately landed? The second missile took down the target. Each missile costs more than $400,000. . Imagine being that, but like, first of all, imagine being the a kicker that misses a kick during a football game. Now, imagine being a fighter pilot that misses. You're marked with a $400,000 rocket missile. Uh, none of the debris from the objects has been found in the Lake Defense Secretary Lloyd Austin, said Monday The Defense Department or d od said President Biden just before 2:42 PM directed the F 16 to fire the missile to shoot down an airborne object flying at nearly 20,000 feet over Lake Huron. The downing over the fourth object was to be destroyed since February 4th when a Chinese spycraft was shot down over south. Now this is an octagonal object, which is different from the iCal object, which is different than the Chinese spy balloon. Okay, so how would one miss a static balloon object? We are not talking about the same thing that we. on Monday and maybe just maybe they had intel that showed that these things were gonna show up. Now it also noted at the bottom of that news hearing that this was an unmanned aircraft according to what they saw. Um, but I'm sure they wouldn't tell us if it was manned. Um, now the one that was shot down over Alaska was cnr. And Silverish Gray. And now we have the article on that says, the US government has announced that it's successfully shot down in an unidentified object over the Alaskan coast. Still a day later officials have yet to identify its owner or purpose. The FBI and Coast Guard and Navy have efforts to recover. The object are currently underway. Um, don't think there's anything a part of this art article that's gonna blow us. All right, now this is coming up where the lawmakers are demanding. Biden. Address the nation on these U F O incurs. . So let's see what he has to say about that Frustration on Capitol Hill is mounting after a string of aerial objects were shot down over the US and Canadian airspace in the last few days, raising a long list of questions that lawmakers say President Biden should publicly address. The President owes the American people an explanation direct and on camera of what we know about these objects and what steps he's taking to protect American Sovereign Aerospace. Marco Rubio, the Vice Chairman of the Intelligence Committee, also joined the calls from President Biden to address the nation. Nor Ed's been around for almost 65 years, he said, and the command in charge of patrolling us and Canadian airspace, we've never shot anything down, and in eight days we've shot down four things. That's a pretty big deal. It doesn't happen every day. Rubio in the tweet. Americans need to hear directly from this about their president today. We have been, and I think it's as transparent as we can be, said John. So basically they're just calling him out to talk about this. Okay? Now, if this is something that is a national security threat, which he said they would have notified us about, which they didn't only until people called them out on it, um, we, we have a right to know that, right? We have a right to know if this is something that we should be concerned about, if we should be seeking shelter, if we should be. Concerned about what's happening over the United States at this very moment and why we're having three separate aerial incidences going on. Because if this is not extraterrestrials, then what is it? Who's doing this? Is it Russia? Is it China? And if so, what are their intentions? Because we know the original balloon was Chinese. Well, maybe, right? We know that, right? But why are they doing this now? What is this escalation of tension? Right? And more recently, The United States called on all citizens to leave Russia recently. Let's see if I can get a date on that. But to me that's the most alarming thing here is this is if nothing crazy is going on here, this is an escalation of military tension between one world superpower and another superpower In the best case scenario. . I mean, obviously not the best case scenario. The best case scenarios is some 16 year old playing with drones that made them look like something nobody's ever seen before. And they're really mad now because they lost all their toys, uh, but . But besides that, what seems to be the best case scenario here is that this is some type of escalation of tensions between military world superpowers during one of the very first hot wars of nations that we are now a part. , especially during the timing of the Nord Stream pipeline coming out as being, you know, our responsibility. So what was I looking up? I don't know. Um, but yeah, so that to me, if it, if nothing else. Oh yeah. Russia. Russia Fleeing. Okay. United States, Russia. Evacuate order. All right, let's see what we have to say here. US orders, family members of the embassy staff to leave Ukraine. Okay. Um, Americans ordered to evacuate Russia, and this was 11 hours ago. Let's see if I can get a better source than this. Uh, Let's see news and let's go past day. All right, here's Reuters. United States tells citizens to leave Russia immediately. Now this is during all of this escalation of tension. This is during the time where we're shooting down multiple UFOs. This is during the time where President Biden has been caught blowing up the North Stream pipeline, which caused a big portion of this upfront part of this war to escalate to where it did. And here's what the article says. United States tells citizens to leave Russia immediately. This is on the 13th. Today, the United States has told its citizens to leave Russia immediately due to the war in Ukraine. In the risk of arbitrary arrest or harassment by Russian law enforcement agencies, um, US citizens residing or traveling in Russia should depart immediately. The US Embassy in Moscow said. Do not travel to Russia. It said in Russia. Security services have arrested US citizens on spurious charges. Singled out US citizens in Russia for detention and harassment. Denied them fair and transparent treatment and convicted them in secret trials or without presenting credible evidence. Russian authorities arbitrarily enforced local laws against US citizens, religious workers, and have opened questionable criminal investigations against US citizens engaged in religious activity, uh, interest. So amidst all of this, we're recalling all US citizens from Russia. So that should is another piece of the puzzle here, right? If, if we're shooting down multiple military aircraft over our airspace, if one of them was China and now we're calling for all US citizens to come back from, from Russia, the likelihood that this is not an escalation of military tensions and this is not some sort of. You know, internal human type of technology that we just don't have access to yet seems to be a higher probability at this point, unless Russia's working with the aliens, in which case, that's an interesting plot twist. . Uh, now, um, one of the last things that we're gonna touch on here is going to be the Jeffrey Epstein document. So here's, here's my deal. Let's close out the U F O thing. I don't know guys, it's going, those are my separate but conjoined theories. If it's a, if it's a, a military escalation of tension, that's highly concerning, right? That means there's a high probability that we may be going to war very shortly if, if, if these types of things have any correlation with each other between the attacks, you know, um, on the North Stream pipeline being released as, as the fault of the United States, of these military aircraft, um, or UFOs that have been shot down three times in US airspace over the last week. All of these things coming together at one time, the train's being derailed and causing massive explosions and releases of, of toxic chemicals. Uh, all of it, all of it seems pretty weird. Now, in the midst of all of this, in the midst of all of this, you have several other things going on, which I will pull up here as well. Uh, I posted this the other day and again, coming. DC Draino. It says, these balloons sure have been a good distraction from Pfizer. Admitting gain of function for covid strains to boost profits in vaccine affecting menstrual cycles. Infertility, hunter Biden's, partial ownership of a Ukrainian biolab and Biden caught blowing up the Nord Stream pipeline. Right? Three huge news stories which have flown under the radar during this time as a result of balloon of a balloon. All right. Now another big one that everybody's alluding to is the fact that Jeffrey Epstein's documents with the names of associates to be made. . All right. Now, if you've been following me for a while, you know that I made my channel building off of, um, all of the stuff that happened at the very beginning following all of the Epstein situations while it was unfolding over a year ago Now. and the Ghislaine Maxwell trial. All right. Um, now this goes on to say that the last batch of documents with the names of those associated with deceased financier, uh, Jeffrey Epstein will be unsealed in the near future. According to media reports, daily mail reported that the material is expected to be made public in the coming months, nearly four years after Epstein took his own life, while incarcerated in the New York Federal Corrections facility. The documents are expected to contain the names of associates, victims, and employees connected to ep. They refer to alleged perpetrators or those accused of serious wrongdoing as well as law enforcement officials and prosecutors. Epstein was associated in friends. Uh, Epsteins was associated in friends with many public figures, incu, including Bill Gates and former President Donald and Bill Clinton. Donald Trump and Bill Clinton. It was not clear if those names will be mentioned in the materials. PR Prince Andrew, who is accused of having sex with Epstein's victim, Virginia Roberts, now Virginia Guff underage and the attorney of Alan Dershowitz are understood to be among the individuals mentioned in the papers. According to the Daily Mail report, the documents have been sealed since Epstein killed himself in 2019, killed himself. Um, in quotes and were use, uh, were using the DEF Defamation case brought by Roberts in 2015 against Max. She was eventually convicted of sex trafficking and recruiting minors for Epstein. The lawsuit was settled in, the materials have now been gradually released ever. Some of the people slated to be identified include John Doe five, A victim who gave evidence at Maxwell's trial using only her first name. The report said another is an assistant district attorney. Another was described as a public figure by Maxwell's lawyers who objected to the name becoming public. John Doe 23 is deceased but was accused of serious wrongdoing. The documents state according to the Daily Mail, and they are not identified by mail or. Name. Okay, now I released Epstein's. Everybody's been calling for this release of the Black book. Like everybody tell us all his associates. I released his black book almost. 10 months ago. It's on my sub sub right now. You can go back in the files of my sub and find the coverage that I did and find this black book that everybody's been talking about. I don't know, I don't believe that's what's being made public here, but it was like basically all of his contact list of everybody who was ever associated with all of the owners of industries, all of the owners of companies, all the financial, JP Morgan Chase, high up people. All of the presidents and all of the, the royalty, all of them, all of the celebrities, all of the musicians were all in this book that I posted, written in Epstein's handwriting. Okay. So it's not like we don't have a clue as to who these people are. Right? I don't know what everybody's waiting for to persecute these people. We already know that Prince Andrew, like, what the, what the hell do you think's gonna happen once Prince Andrew's name is is released on this? You think he's all of a sudden gonna be prosecuted? Nothing's gonna happen, right? And you've probably heard this before. The reason they haven't released this list is because they are on it. High level judges, high level politicians, very well-known celebrities, presidents, kings of countries, royalty high Lee famous mu musicians and actors, all of them. Bill Gates, him. Is on that list, and we know it as a fact, and nothing's happening to him right now. In fact, the establishment is taking his advice on every little nutritional thing he ever feeds them with no positioning as a doctor to be able to do so. No credentials to be able to do so. Okay, so let's keep that at the forefront of our minds when all of this stuff is coming out too, that we have other things to pay attention to that are going. Don't let a Chinese spy balloon distract you from the fact that some of the most egregious perpetrators of sexual assault against underage children is about to be released very, very shortly. So in the meantime, keep your eyes open. Okay. Maybe get prepared a little bit. Right? And I'm not an alarmist, I'm not calling you to, you know, go stock up on, on, you know, I don. Beans. But I do think that if, if all of these things are escalating to the way that they are, the potential likelihood of something happening where you need to be prepared is just getting higher. Right? So do what you need to do to protect your family. Right. Uh, . And in the meantime, sign up for my ck red pill revolution.ck.com. Um, go ahead and subscribe and, uh, leave a five star review. I would appreciate it again, from the bottom of my heart. Uh, yeah. Have a great day guys. Welcome to the Revolution. Thank you.
It's National Cancer Prevention Month and I'm digging deep about what that means for us cancer survivors and thrivers. Sure, mammograms and self-breast exams are important screenings for early detection but that's one step ahead of prevention. Prevention is all the things you can do to keep your body in an optimally functioning state. When it comes to the preventative measures we can take, they often don't align with the desire to feel “normal” or to do things the way same way as before cancer. But were you really healthy before cancer? No. Because cancer is a process that can take a long time before it's detectable. It's during that time that you can explore your thoughts about the lifestyle choices you're making and work on prevention. Even after a diagnosis it's important to be able to look back and with gentle self-honesty, get really curious about things you may have thought were fine at that time and ask yourself now if continuing those habits truly supports your optimal health. In this week's episode I'll give you some surprising insights from leading cancer research centers that may inspire you to reevaluate your normal in favor of doing something exceptional for yourself. Referred to in this episode: 90 Days of Wellness Cleveland Clinic Breast Cancer Recurrence Journal of the National Cancer Institute study Nutrition Genome
In this episode we discuss focal therapy for the treatment of prostate cancer. Historically, men diagnosed with localized prostate cancer have had to choose between two treatment options: surgery and radiation therapy. Both options involve treating the entire prostate gland, regardless of the size, location, or number of cancerous tumors. Recently, however, more localized treatment options have become available for prostate cancer that involve focally treating only the tumors, rather than the entire prostate gland. So, what are these focal therapies? How do they work? What risks are involved? What advantages do they have over traditional therapies? And, probably most importantly, how successful are they at actually curing prostate cancer? To answer these questions and many more, we turned to a true expert. Dr. Arvin George is an Associate Professor of Urology at the University of Michigan. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology at the Hofstra North Shore-LIJ School of Medicine. He remained to complete his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health. Dr. George's research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer. He is an active member of the American Urological Association, Society of Urologic Oncology, the Endourological Society, and the American College of Surgeons.#prostate #prostatecancertreatment #prostatecancer #focaltherapy
This episode follows 2 Kidney Cancer expert Urologists in understanding Kidney tumors from diagnosis to treatment options. Guest: John L. Gore, M.D. Professor of Urology, Professor of Surgery, Health Services Researcher, University of Washington. Urologist, surgeon, clinician, researcher, educator and expert in clinical care guidelines and outcomes. Dr. Gore is the PI of a large pragmatic trial in bladder cancer, and a quality of care expert. He previously served as the American Urological Association (AUA) representative to the National Quality Forum, which endorses national health care performance measures, and has been on guidelines panels for the National Comprehensive Cancer Network (NCCN) for kidney cancer, and the AUA for bladder cancer. Brian Shuch, MD is the Director of the Kidney Cancer Program and the Alvin & Carrie Meinhardt Endowed Chair in Kidney Cancer Research. He completed his urology training at UCLA followed by a Urologic Oncology Fellowship at the National Cancer Institute. He is an accomplished surgeon (open/laparoscopic/robotic surgery and percutaneous ablations) and clinical/translational researcher. He serves in leadership positions within various kidney cancer research organizations such as SWOG and the Society of Urologic Oncology. He is recognized as an expert in the genetics of kidney cancer and runs a translational research program with over 140 peers reviewed publications including primary research published in prestigious journals such as Nature, Nature Genetics, Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, and Clinical Cancer Research. He is one of the few clinicians to bring bench science to the bedside in an upcoming therapeutic clinical trial for metastatic kidney cancer. During This Episode We Discuss: The types of Kidney Cancer Non cancerous kidney cysts (benign) versus cancerous kidney cysts, Solid kidney tumors, benign and malignant Diagnosis of kidney cancers: Imaging and Biopsy Risk factors for kidney cancers Genomics of kidney cancer Treatment of kidney cancer: Localized and Metastatic Quotes (Tweetables) Back in the olden days we used to talk about the triad of three symptoms people associated with kidney cancer. Those three symptoms were hematuria or blood in the urine, palpable mass, and flank pain. Realistically in 2023 this triad happens less than 1% of the time. What has changed is that there is a much higher frequency of use of imaging to diagnose problems in our bodies. Kidney cancer is one of the fastest growing cancer types in terms of it's incidence, because of incidental detection. Dr Gore Regarding tumor size, it all depends on the scenario.The larger the lesion the more concerning it is for cancer, but even a 1 cm tumor can have some aggressive elements. There is not an absolute size where you say that a tumor below this threshold cannot be a cancer. Dr Shuch Most kidney cancers are what we would call sporadic, in that it occurs in the absence of known risk factors. The 2 biggest risk factors that are more behavioral are smoking and obesity. Dr Gore Recommended Resources: KCA: Kidney Cancer Association www.kidneycancer.org Kidney Can www.kidneycan.org KC Cure www.kccure.org American Cancer Society Fred Hutchinson UCLA
One year ago, President Biden reignited the Cancer Moonshot initiative and set bold new goals to reduce the cancer death rate by at least 50% over the next 25 years and to improve the lives of cancer patients and survivors, their caregivers and families. In an interagency effort, the White House Cancer Cabinet has brought together leaders from across government to progress priority actions on ending cancer as we know it. Dr. Danielle Carnival, White House Cancer Moonshot Coordinator, lays out those actions and the initial progress being made toward these goals.
This episode is brought to you by InsideTracker, Mitopure, and Pique.Many people are confused about how much protein they should be eating and where to get it. Adequate protein is vital in building muscle mass, an essential component of maintaining a healthy weight. It's also a key factor in reducing the risk of chronic disease, which improves our healthspan and longevity. Research shows that higher protein intake is correlated to better body composition, insulin control, satiation, and more.In today's episode, I talk with Dr. Gabrielle Lyon, Dr. David Heber, and Dr. Frank Lipman about why it's necessary to get adequate protein in your diet every day and how to do that, whether you're a meat-eater or not.Dr. Gabrielle Lyon is an integrative physician who completed her fellowship in nutritional sciences and geriatrics at Washington University, St. Louis. She is board certified in family medicine and completed her undergraduate work in human nutrition vitamin and mineral metabolism. Dr. Lyon works closely with current and retired Special Operations military operators as a part of the Task Force Dagger Foundation.Dr. Heber is the founding director of the UCLA Center for Human Nutrition, a professor of medicine and public health, and the founding chief of the Division of Clinical Nutrition in UCLA's Department of Medicine. Dr. Heber also directs the National Cancer Institute-funded clinical nutrition research unit and the National Institute of Health's nutrition and obesity training grants at UCLA.Dr. Frank Lipman is recognized as a vocal pioneer of integrative and Functional Medicine (or what he calls “good medicine”). Dr. Lipman is the founder of Eleven Eleven Wellness Center and the Chief Medical Officer at The Well. He is a sought-after international speaker and the bestselling author of six books—How to Be Well, The New Health Rules, Young and Slim for Life, Revive, and Total Renewal—and his newest book, The New Rules of Aging Well: A Simple Program for Immune Resilience, Strength, and Vitality.This episode is brought to you by InsideTracker, Mitopure, and Pique. Right now InsideTracker is offering my community 20% off at insidetracker.com/drhyman.Get 10% off Mitopure at timelinenutrition.com/drhyman and use code DRHYMAN10 at checkout.Right now you can take advantage of Pique's limited-time special offer on your first month's supply of their Sun Goddess Matcha. Just head over to piquelife.com/farmacy for 15% off plus free shipping on your first month's supply.Full-length episodes of these interviews can be found here:Dr. Gabrielle LyonDr. David HeberDr. Frank LipmanDr. Gabrielle Lyon Hosted on Acast. See acast.com/privacy for more information.